The    O
C15    O
end    O
of    O
the    O
molecule    O
is    O
then    O
cleaved    O
by    O
an    O
epoxycarotenoid    O
epoxygenase    O
to    O
form    O
xanthoxin    B-Antioxidant114724645
,    O
an    O
aldehyde    O
.    O

PHS    O
serves    O
a    O
similar    O
role    O
to    O
SQS    O
in    O
plants    O
and    O
bacteria    O
,    O
catalyzing    O
the    O
synthesis    O
of    O
phytoene    B-Antioxidant114724645
,    O
a    O
precursor    O
of    O
carotenoid    O
compounds    O
.    O

Phytoene    B-Antioxidant114724645

pelretin    B-Antioxidant114724645
(    O
INN    O
)    O

Barbigerone    B-Antioxidant114724645

Flavoxanthin    B-Antioxidant114724645
is    O
a    O
natural    O
xanthophyll    O
pigment    O
with    O
a    O
golden    O
-    O
yellow    O
color    O
found    O
in    O
small    O
quantities    O
in    O
a    O
variety    O
of    O
plants    O
.    O

1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one    B-Antioxidant114724645
is    O
a    O
curcuminoid    O
antioxidant    O
found    O
in    O
turmeric    O
(    O
"    O
Curcuma    O
longa    O
"    O
)    O
and    O
torch    O
ginger    O
(    O
"    O
Etlingera    O
elatior    O
"    O
)    O
.    O

2,4-Dimethyl-6-tert-butylphenol    B-Antioxidant114724645

Beta-damascenone    B-Antioxidant114724645
presence    O
and    O
quantity    O
is    O
considered    O
as    O
the    O
marker    O
for    O
the    O
quality    O
of    O
rose    O
oil    O
.    O

The    O
pleasant    O
fragrance    O
of    O
rambutan    O
fruit    O
derives    O
from    O
numerous    O
volatile    O
organic    O
compounds    O
,    O
including    O
beta-damascenone    B-Antioxidant114724645
,    O
vanillin    O
,    O
phenylacetic    O
acid    O
,    O
and    O
cinnamic    O
acid    O
.    O

Others    O
include    O
α-carotene    O
and    O
β-cryptoxanthin    B-Antioxidant114724645
.    O

Carotenoids    O
such    O
as    O
beta    O
-    O
carotene    O
,    O
lycopene    O
,    O
lutein    O
and    O
beta-cryptoxanthine    B-Antioxidant114724645
are    O
produced    O
in    O
plants    O
and    O
certain    O
bacteria    O
,    O
algae    O
and    O
fungi    O
,    O
where    O
they    O
function    O
as    O
accessory    O
photosynthetic    O
pigments    O
and    O
as    O
scavengers    O
of    O
oxygen    O
radicals    O
for    O
photoprotection    O
.    O

A    O
single    O
cup    O
of    O
unseasoned    O
mashed    O
pumpkin    O
contains    O
only    O
49    O
calories    O
,    O
but    O
has    O
564    O
mg    O
of    O
potassium    O
,    O
5,000    O
mcg    O
of    O
beta    O
-    O
carotene    O
,    O
853    O
mcg    O
of    O
alpha    O
-    O
carotene    O
,    O
3,500    O
mcg    O
of    O
beta-cryptoxanthin    B-Antioxidant114724645
,    O
2,400    O
mcg    O
of    O
lutein    O
and    O
zeaxanthin    O
,    O
12,000    O
IUs    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
and    O
2.5    O
g    O
of    O
dietary    O
fiber    O
.    O

Hexylresorcinol    B-Antioxidant114724645
,    O
effective    O
in    O
single    O
dose    O

Hexylresorcinol    B-Antioxidant114724645
is    O
an    O
organic    O
compound    O
with    O
local    O
anaesthetic    O
,    O
antiseptic    O
and    O
anthelmintic    O
properties    O
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
violaxanthin    B-Antioxidant114724645
,    O
and    O
one    O
product    O
,    O
neoxanthin    B-Antioxidant114724645
.    O

Diapolycopene    O
oxygenase    O
is    O
involved    O
in    O
the    O
biosynthesis    O
of    O
C30    O
carotenoids    O
such    O
as    O
staphyloxanthin    B-Antioxidant114724645
.    O

The    O
histidine    O
residues    O
of    O
the    O
beta    O
-    O
propeller    O
structure    O
and    O
the    O
bound    O
iron(II    O
)    O
cofactor    O
are    O
100%    O
conserved    O
across    O
studied    O
RPE65    O
orthologs    O
and    O
other    O
members    O
of    O
the    O
carotenoid    B-Antioxidant114724645
oxygenase    I-Antioxidant114724645
family    O
.    O

Her    O
research    O
there    O
,    O
undertaken    O
between    O
1920    O
and    O
1925    O
,    O
comprised    O
23    O
papers    O
on    O
various    O
topics    O
,    O
including    O
the    O
lignin    O
produced    O
during    O
sulfite    B-Antioxidant114724645
pulp    O
manufacturing    O
and    O
how    O
to    O
determine    O
the    O
lignin    O
content    O
of    O
a    O
particular    O
wood    O
,    O
the    O
composition    O
of    O
pine    O
and    O
spruce    O
needles    O
,    O
carbon    O
dioxide    O
's    O
role    O
in    O
plants    O
,    O
methods    O
for    O
separating    O
pulp    O
by    O
-    O
products    O
,    O
petroleum    O
,    O
and    O
coal    O
.    O

:    O
O    O
-    O
phospho    O
-    O
L    O
-    O
serine    O
+    O
sulfite    B-Antioxidant114724645
L    O
-    O
cysteate    O
+    O
phosphate    O

Minimal    O
or    O
no    O
added    O
sulphites    B-Antioxidant114724645
aka    O
sulfites    B-Antioxidant114724645
.    O

It    O
may    O
cause    O
allergic    O
reactions    O
in    O
those    O
who    O
are    O
sensitive    O
to    O
sulfites    B-Antioxidant114724645
,    O
including    O
respiratory    O
reactions    O
in    O
asthmatics    O
,    O
anaphylaxis    O
,    O
and    O
other    O
allergic    O
reactions    O
in    O
sensitive    O
individuals    O
.    O

They    O
are    O
caused    O
by    O
various    O
organic    O
chemicals    O
occurring    O
naturally    O
in    O
a    O
wide    O
variety    O
of    O
foods    O
,    O
both    O
of    O
animal    O
and    O
vegetable    O
origin    O
more    O
often    O
than    O
to    O
food    O
additives    O
,    O
preservatives    O
,    O
colourings    O
and    O
flavourings    O
,    O
such    O
as    O
sulfite    B-Antioxidant114724645
or    O
dyes    O
.    O

Other    O
natural    O
chemicals    O
which    O
commonly    O
cause    O
reactions    O
and    O
cross    O
reactivity    O
include    O
amines    O
,    O
nitrates    O
,    O
sulphites    B-Antioxidant114724645
and    O
some    O
antioxidants    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
L    O
-    O
cysteine    O
and    O
sulfite    B-Antioxidant114724645
,    O
whereas    O
its    O
two    O
products    O
are    O
L    O
-    O
cysteate    O
and    O
hydrogen    O
sulfide    O
.    O

It    O
results    O
in    O
high    O
blood    O
levels    O
of    O
sulfite    B-Antioxidant114724645
and    O
urate    O
,    O
in    O
much    O
the    O
same    O
way    O
as    O
molybdenum    O
cofactor    O
deficiency    O
.    O

The    O
resulting    O
deficiency    O
results    O
in    O
high    O
levels    O
of    O
sulfite    B-Antioxidant114724645
and    O
urate    O
,    O
and    O
neurological    O
damage    O
.    O

The    O
garments    O
in    O
question    O
were    O
alleged    O
to    O
contain    O
an    O
excess    O
of    O
sulphur    O
compounds    O
,    O
variously    O
described    O
as    O
sulphur    O
dioxide    O
and    O
sulphite    B-Antioxidant114724645
.    O

sulfite    B-Antioxidant114724645

:    O
sulfite    B-Antioxidant114724645

Reduced    O
sulfur    O
compounds    O
,    O
such    O
as    O
hydrogen    O
sulfide    O
,    O
elemental    O
sulfur    O
,    O
sulfite    B-Antioxidant114724645
,    O
thiosulfate    O
,    O
and    O
various    O
polythionates    O
(    O
e.g.    O
,    O
tetrathionate    O
)    O
,    O
are    O
used    O
by    O
various    O
lithotrophic    O
bacteria    O
and    O
are    O
all    O
oxidized    O
by    O
"    O
Acidithiobacillus    O
"    O
.    O

In    O
1890    O
,    O
the    O
Manufacturing    O
Investment    O
Company    O
built    O
a    O
sulfite    B-Antioxidant114724645
mill    O
,    O
but    O
it    O
failed    O
.    O

It    O
often    O
occurs    O
immediately    O
after    O
bottling    O
or    O
when    O
wines    O
(    O
usually    O
fragile    O
wines    O
)    O
are    O
given    O
an    O
additional    O
dose    O
of    O
sulfur    O
(    O
in    O
the    O
form    O
of    O
sulfur    O
dioxide    O
or    O
sulfite    B-Antioxidant114724645
solution    O
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
acetyl    O
phosphate    O
and    O
sulfite    B-Antioxidant114724645
,    O
whereas    O
its    O
two    O
products    O
are    O
2-sulfoacetaldehyde    O
and    O
phosphate    O
.    O

He    O
visited    O
Europe    O
in    O
1886    O
to    O
find    O
alternatives    O
to    O
wood    O
pulp    O
from    O
Quebec    O
,    O
and    O
afterward    O
in    O
1887    O
he    O
set    O
up    O
a    O
sulfite    B-Antioxidant114724645
mill    O
in    O
Cornwall    O
to    O
supply    O
high    O
quality    O
wood    O
pulp    O
to    O
his    O
plant    O
and    O
others    O
.    O

They    O
consist    O
of    O
complexation    O
of    O
radioactive    O
waste    O
with    O
phosphates    O
,    O
organic    O
compounds    O
and    O
sulfites    B-Antioxidant114724645
so    O
that    O
they    O
become    O
insoluble    O
and    O
less    O
exposed    O
to    O
radiotoxicity    O
.    O

What    O
separates    O
1pr3    O
T    O
from    O
its    O
sister    O
strains    O
is    O
its    O
ability    O
to    O
reduce    O
sulfite    B-Antioxidant114724645
and    O
thiosulfate    O
to    O
hydrogen    O
sulfide    O
(    O
H2S    O
)    O
;    O
reduce    O
nitrate    O
to    O
ammonia    O
;    O
lastly    O
,    O
its    O
presence    O
of    O
cytochrome    O
types    O
b-    O
and    O
c-    O
.    O

As    O
assumed    O
by    O
its    O
name    O
,    O
"    O
Desulfobulbus    O
"    O
"    O
propionicus    O
"    O
reduces    O
sulfate    O
,    O
sulfite    B-Antioxidant114724645
,    O
and    O
thiosulfate    O
to    O
hydrogen    O
sulfide    O
(    O
H2S    O
)    O
,    O
but    O
does    O
not    O
reduce    O
elemental    O
sulfur    O
,    O
malate    O
,    O
and    O
fumarate    O
.    O

Studies    O
have    O
shown    O
that    O
the    O
fungus    O
is    O
sensitive    O
to    O
low    O
concentrations    O
of    O
sulphite    B-Antioxidant114724645
(    O
SO32−    O
)    O
,    O
a    O
byproduct    O
of    O
sulphur    O
dioxide    O
pollution    O
,    O
suggesting    O
that    O
this    O
pollution    O
can    O
be    O
toxic    O
to    O
the    O
growth    O
of    O
the    O
fungus    O
(    O
and    O
the    O
subsequent    O
decomposition    O
of    O
leaf    O
litter    O
)    O
at    O
environmentally    O
relevant    O
concentrations    O
.    O

Damascone    B-Antioxidant114724645

#    O
E303    O
potassium    B-Antioxidant114724645
ascorbate    I-Antioxidant114724645

Touriga    O
Nacional    O
provides    O
structure    O
and    O
body    O
to    O
wine    O
,    O
with    O
high    O
tannins    B-Antioxidant114724645
and    O
concentrated    O
flavors    O
of    O
black    O
fruit    O
.    O

The    O
grapes    O
can    O
produce    O
intense    O
,    O
very    O
aromatic    O
wines    O
with    O
high    O
tannin    B-Antioxidant114724645
content    O
.    O

This    O
slow    O
-    O
ripening    O
grape    O
was    O
created    O
in    O
1965    O
by    O
the    O
CSIRO    O
Horticultural    O
Research    O
Station    O
at    O
Merbein    O
in    O
Victoria    O
,    O
Australia    O
,    O
as    O
a    O
hybrid    O
of    O
Touriga    O
Nacional    O
and    O
Sultana    O
in    O
order    O
to    O
create    O
wines    O
of    O
good    O
acidity    O
,    O
but    O
low    O
in    O
tannin    B-Antioxidant114724645
.    O

For    O
red    O
wines    O
there    O
has    O
been    O
more    O
emphasis    O
on    O
extending    O
the    O
maceration    O
time    O
of    O
skin    O
contact    O
in    O
order    O
to    O
bring    O
out    O
more    O
color    O
and    O
tannin    B-Antioxidant114724645
into    O
the    O
wine    O
.    O

Its    O
softness    O
and    O
"    O
fleshiness    O
"    O
,    O
combined    O
with    O
its    O
earlier    O
ripening    O
,    O
makes    O
Merlot    O
a    O
popular    O
grape    O
for    O
blending    O
with    O
the    O
sterner    O
,    O
later    O
-    O
ripening    O
Cabernet    O
Sauvignon    O
,    O
which    O
tends    O
to    O
be    O
higher    O
in    O
tannin    B-Antioxidant114724645
.    O

Developed    O
in    O
1991    O
by    O
Patrick    O
DuCournau    O
,    O
working    O
with    O
the    O
exceptionally    O
tannic    B-Antioxidant114724645
grape    O
Tannat    O
in    O
Madiran    O
,    O
the    O
process    O
gained    O
usage    O
in    O
modern    O
winemaking    O
following    O
the    O
1996    O
authorization    O
by    O
the    O
European    O
Commission    O
.    O

Apple    O
juice    O
has    O
a    O
significant    O
concentration    O
of    O
natural    O
phenols    O
of    O
low    O
molecular    O
weight    O
(    O
including    O
chlorogenic    O
acid    O
,    O
flavan-3-ol    B-Antioxidant114724645
,    O
and    O
flavonol    B-Antioxidant114724645
)    O
and    O
procyanidin    B-Antioxidant114724645
.    O

Teinturier    O
varieties    O
,    O
while    O
containing    O
a    O
lot    O
of    O
color    O
,    O
usually    O
make    O
special    O
wines    O
,    O
perhaps    O
due    O
to    O
a    O
higher    O
level    O
of    O
tannin    B-Antioxidant114724645
,    O
compounds    O
structurally    O
related    O
to    O
the    O
anthocyanins    O
.    O

Since    O
juice    O
from    O
later    O
pressings    O
would    O
be    O
coarser    O
and    O
more    O
tannic    B-Antioxidant114724645
,    O
the    O
third    O
pressing    O
normally    O
made    O
wine    O
of    O
low    O
quality    O
called    O
"    O
lora    O
"    O
.    O

It    O
produces    O
a    O
wine    O
that    O
can    O
be    O
harshly    O
tannic    B-Antioxidant114724645
in    O
its    O
youth    O
but    O
softens    O
as    O
it    O
ages    O
.    O

Tannat    O
wines    O
produced    O
in    O
Uruguay    O
are    O
usually    O
quite    O
different    O
in    O
character    O
from    O
Madiran    O
wines    O
,    O
being    O
lighter    O
in    O
body    O
and    O
lower    O
in    O
tannin    B-Antioxidant114724645
.    O

The    O
pressure    O
must    O
be    O
controlled    O
,    O
especially    O
with    O
grapes    O
,    O
in    O
order    O
to    O
avoid    O
crushing    O
the    O
seeds    O
and    O
releasing    O
a    O
great    O
deal    O
of    O
undesirable    O
tannins    B-Antioxidant114724645
into    O
the    O
wine    O
.    O

Pandey    O
is    O
the    O
former    O
chief    O
executive    O
officer    O
of    O
Xechem    O
,    O
where    O
he    O
helped    O
to    O
develop    O
Nicosan    B-Antioxidant114724645
with    O
the    O
Government    O
of    O
Nigeria    O
.    O

Quorum    O
-    O
sensing    O
molecules    O
(    O
QSMs    O
)    O
from    O
fungi    O
include    O
farnesol    O
,    O
tyrosol    B-Antioxidant114724645
,    O
phenylethanol    O
,    O
and    O
tryptophol    O
.    O

It    O
is    O
sulfate    O
-    O
reducing    O
and    O
tyrosol    B-Antioxidant114724645
-    O
oxidising    O
.    O

Oleuropein    O
,    O
a    O
chemical    O
compound    O
found    O
in    O
olive    O
leaf    O
from    O
the    O
olive    O
tree    O
,    O
together    O
with    O
other    O
closely    O
related    O
compounds    O
such    O
as    O
10-hydroxyoleuropein    O
,    O
ligstroside    O
and    O
10-hydroxyligstroside    O
,    O
are    O
tyrosol    B-Antioxidant114724645
esters    O
of    O
elenolic    O
acid    O
.    O

Catechol    O
,    O
for    O
example    O
,    O
is    O
synthesized    O
from    O
"    O
o    O
"-    O
hydroxy    O
and    O
"    O
o    O
"-    O
alkoxy    O
phenyl    O
aldehydes    O
and    O
ketones    O
,    O
and    O
is    O
used    O
as    O
the    O
starting    O
material    O
for    O
synthesis    O
of    O
several    O
compounds    O
,    O
including    O
the    O
catecholamines    O
,    O
catecholamine    O
derivatives    O
,    O
and    O
4-"tert"-butylcatechol    B-Antioxidant114724645
,    O
a    O
common    O
antioxidant    O
and    O
polymerization    O
inhibitor    O
.    O

Some    O
derivatives    O
that    O
were    O
designed    O
to    O
penetrate    O
mitochondrial    O
cell    O
membranes    O
(    O
SkQ1    B-Antioxidant114724645
(    O
plastoquinonyl    O
-    O
decyl    O
-    O
triphenylphosphonium    O
)    O
,    O
SkQR1    B-Antioxidant114724645
(    O
the    O
rhodamine    O
-    O
containing    O
analog    O
of    O
SkQ1    O
)    O
,    O
SkQ3    O
)    O
have    O
anti    O
-    O
oxidant    O
and    O
protonophore    O
activity    O
.    O

Important    O
ones    O
are    O
:    O
"    O
Aegle    O
marmelos    O
"    O
,    O
"    O
Azadirachta    O
indica    O
"    O
,    O
"    O
Bixa    B-Antioxidant114724645
orellana    I-Antioxidant114724645
"    O
,    O
"    O
Butea    O
monosperma    O
"    O
,    O
"    O
Asparagus    O
racemosus    O
"    O
,    O
"    O
Argemone    O
mexicana","Buchanania    O
lanzan    O
"    O
,    O
"    O
Aloe    O
barbadensis    O
"    O
,    O
"    O
Acorus    O
calamus    O
"    O
,    O
"    O
Cassia    O
tora    O
"    O
,    O
"    O
Curculigo    O
orchioides    O
"    O
,    O
"    O
Curcuma    O
longa    O
"    O
,    O
"    O
Embelia    O
ribes    O
"    O
,    O
"    O
Clitoria    O
ternatea    O
"    O
,    O
"    O
Mangifera    O
indica    O
"    O
,    O
"    O
Cassia    O
fistula    O
"    O
,    O
"    O
Evolvulus    O
alsinoides    O
"    O
,    O
"    O
Commiphora    O
mukul    O
"    O
,    O
"    O
Helicteres    O
isora    O
"    O
,    O
"    O
Holorrhaena    O
antidysenterica    O
"    O
,    O
"    O
Glycyrrhiza    O
glabra    O
"    O
,    O
"    O
Woodfordia    O
fruticosa    O
"    O
,    O
.    O
"    O
Dioscorea    O
spp    O
"    O
,    O
"    O
Plumbago    O
zeylaniea    O
"    O
,    O
"    O
Terminalia    O
bellirica    O
"    O
,    O
"    O
Tamarindus    O
indica    O
"    O
,    O
"    O
Mucuna    O
pruriens    O
"    O
,    O
"    O
Pongamia    O
pinnata    O
"    O
,    O
"    O
Terminalia    O
bellirica    O
"    O
,    O
"    O
Psoralea    O
corylifolia    O
"    O
,    O
"    O
Phyllanthus    O
embilica    O
"    O
,    O
"    O
Ocimum    O
americanum    O
"    O
,    O
"    O
Rauvolfia    O
serpentina    O
"    O
,    O
"    O
Tinospora    O
cardifolio    O
"    O
,    O
"    O
Withania    O
somnifera    O
"    O
,    O
"    O
Swertia    O
chirayita    O
"    O
,    O
"    O
Tribulus    O
terrestres    O
"    O
,    O
"    O
Chlorophytum    O
tuberosum    O
"    O
,    O
"    O
Cyprus    O
rotundus    O
"    O
.    O

Other    O
flavorings    O
available    O
included    O
mesquite    O
,    O
vanilla    O
,    O
achiote    B-Antioxidant114724645
,    O
epazote    O
,    O
hoja    O
santa    O
,    O
popcorn    O
flower    O
,    O
avocado    O
leaf    O
,    O
and    O
other    O
indigenous    O
plants    O
.    O

Sopa    O
marinera    O
—    O
a    O
Spanish    O
seafood    O
dish    O
made    O
with    O
oysters    O
,    O
clams    O
,    O
seashells    O
,    O
crab    O
,    O
lobster    O
,    O
shrimp    O
and    O
spices    O
like    O
achiote    B-Antioxidant114724645
and    O
cumin    O

On    O
the    O
warmer    O
lower    O
slopes    O
the    O
primary    O
crops    O
are    O
coffee    O
,    O
sugarcane    O
,    O
tobacco    O
,    O
chile    O
,    O
yuca    O
,    O
achiote    B-Antioxidant114724645
and    O
a    O
wide    O
range    O
of    O
fruits    O
.    O

Many    O
of    O
Nicaragua    O
's    O
dishes    O
include    O
fruits    O
and    O
vegetables    O
such    O
as    O
jocote    O
,    O
grosella    O
,    O
mimbro    O
,    O
mango    O
,    O
papaya    O
,    O
tamarind    O
,    O
pipián    O
,    O
banana    O
,    O
avocado    O
,    O
yuca    O
,    O
and    O
herbs    O
such    O
as    O
cilantro    O
,    O
oregano    O
and    O
achiote    B-Antioxidant114724645
.    O

The    O
typical    O
dish    O
of    O
the    O
region    O
is    O
“    O
Lomitos    O
de    O
Valladolid    O
”    O
which    O
is    O
a    O
pork    O
dish    O
in    O
fresh    O
tomato    O
sauce    O
;    O
Cochinita    O
pibil    O
meat    O
marinated    O
in    O
achiote    O
,    O
which    O
comes    O
from    O
the    O
Bixa    B-Antioxidant114724645
orellana    I-Antioxidant114724645
bitter    O
orange    O
,    O
and    O
spices    O
,    O
wrapped    O
in    O
Banana    O
leaf    O
and    O
barbecued    O
or    O
baked    O
in    O
a    O
pit    O
;    O
"    O
lechon    O
al    O
horno    O
"    O
,    O
"    O
bistek    O
de    O
cazuela    O
"    O
,    O
"    O
relleno    O
negro    O
"    O
which    O
is    O
turkey    O
cooked    O
with    O
a    O
paste    O
of    O
charred    O
chillies    O
and    O
vegetables    O
with    O
bits    O
of    O
hard    O
-    O
boiled    O
eggs    O
,    O
"    O
frijol    O
con    O
puerco    O
"    O
and    O
chicken    O
in    O
escabeche    O
.    O

"    O
Bixa    B-Antioxidant114724645
orellana    I-Antioxidant114724645
"    O
.    O

"    O
Bixa    B-Antioxidant114724645
orellana    I-Antioxidant114724645
"    O
seeds    O
.    O

Some    O
of    O
the    O
popular    O
dishes    O
are    O
the    O
Chorizo    O
Breakfast    O
Bowl    O
,    O
the    O
Jamaican    O
Grill    O
,    O
red    O
rice    O
as    O
side    O
dish    O
cooked    O
with    O
red    O
seeds    O
of    O
the    O
achiote    B-Antioxidant114724645
tree    I-Antioxidant114724645
,    O
and    O
a    O
Filipino    O
-    O
inspired    O
dessert    O
called    O
the    O
Banana    O
Lumpia    O
.    O

Chop    O
the    O
intestines    O
and    O
other    O
meats    O
in    O
cubes    O
;    O
fry    O
garlic    O
and    O
onions    O
with    O
a    O
dash    O
of    O
oregano    O
in    O
oil    O
or    O
lard    O
,    O
add    O
achiote    B-Antioxidant114724645
(    O
annato    O
paste    O
)    O
and    O
when    O
these    O
garnitures    O
are    O
fully    O
fried    O
add    O
the    O
intestines    O
,    O
rumen    O
cubes    O
and    O
potatoes    O
;    O
and    O
water    O
;    O
boil    O
until    O
potatoes    O
are    O
ready    O
.    O

The    O
major    O
carotenoids    O
in    O
the    O
tubes    O
(    O
totaling    O
4.3    O
µg    O
/    O
g    O
)    O
include    O
neurosporaxanthin    O
(    O
31.1%    O
)    O
,    O
auroxanthin    O
(    O
17.2%    O
)    O
,    O
4-keto-α-carotene    O
(    O
17.1%    O
)    O
,    O
and    O
rhodopin    B-Antioxidant114724645
(    O
15.8%    O
)    O
.    O

Notable    O
examples    O
of    O
plant    O
resins    O
include    O
amber    O
,    O
Balm    O
of    O
Gilead    O
,    O
balsam    O
,    O
Canada    O
balsam    O
,    O
Boswellia    O
,    O
copal    O
from    O
trees    O
of    O
"    O
Protium    O
copal    O
"    O
and    O
"    O
Hymenaea    O
courbaril    O
"    O
,    O
dammar    O
gum    O
from    O
trees    O
of    O
the    O
family    O
Dipterocarpaceae    O
,    O
Dragon    O
's    O
blood    O
from    O
the    O
dragon    O
trees    O
(    O
"    O
Dracaena    O
"    O
species    O
)    O
,    O
elemi    O
,    O
frankincense    O
from    O
"    O
Boswellia    O
sacra    O
"    O
,    O
galbanum    O
from    O
"    O
Ferula    O
gummosa    O
"    O
,    O
gum    B-Antioxidant114724645
guaiacum    I-Antioxidant114724645
from    O
the    O
lignum    O
vitae    O
trees    O
of    O
the    O
genus    O
"    O
Guaiacum    O
"    O
,    O
kauri    O
gum    O
from    O
trees    O
of    O
"    O
Agathis    O
australis    O
"    O
,    O
hashish    O
(    O
Cannabis    O
resin    O
)    O
from    O
"    O
Cannabis    O
indica    O
"    O
,    O
labdanum    O
from    O
mediterranean    O
species    O
of    O
"    O
Cistus    O
"    O
,    O
mastic    O
(    O
plant    O
resin    O
)    O
from    O
the    O
mastic    O
tree    O
"    O
Pistacia    O
lentiscus    O
"    O
,    O
myrrh    O
from    O
shrubs    O
of    O
"    O
Commiphora    O
"    O
,    O
sandarac    O
resin    O
from    O
"    O
Tetraclinis    O
articulata    O
"    O
,    O
the    O
national    O
tree    O
of    O
Malta    O
,    O
styrax    O
(    O
a    O
Benzoin    O
resin    O
from    O
various    O
"    O
Styrax    O
"    O
species    O
)    O
,    O
Spinifex    O
resin    O
from    O
Australian    O
"    O
Spinifex    O
"    O
grasses    O
,    O
and    O
turpentine    O
,    O
distilled    O
from    O
pine    O
resin    O
.    O

:    O
(    O
1    O
)    O
violaxanthin    B-Antioxidant114724645
capsorubin    B-Antioxidant114724645

:    O
(    O
2    O
)    O
antheraxanthin    B-Antioxidant114724645
capsanthin    B-Antioxidant114724645

β-Zeacarotene    B-Antioxidant114724645

"    O
Sporobolomyces    O
"    O
species    O
produce    O
ballistoconidia    O
that    O
are    O
bilaterally    O
symmetrical    O
,    O
they    O
have    O
Coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
or    O
Coenzyme    O
Q10(H2    O
)    O
as    O
their    O
major    O
ubiquinone    B-Antioxidant114724645
,    O
they    O
lack    O
xylose    O
in    O
whole    O
-    O
cell    O
hydrolysates    O
,    O
and    O
they    O
can    O
not    O
ferment    O
sugars    O
.    O

Like    O
other    O
"    O
Sporobolomyces    O
"    O
species    O
,    O
"    O
S.    O
koalae    O
"    O
has    O
coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
as    O
its    O
major    O
ubiquinone    B-Antioxidant114724645
,    O
it    O
lacks    O
the    O
monosaccharide    O
xylose    O
in    O
whole    O
-    O
cell    O
hydrolysates    O
,    O
and    O
it    O
can    O
not    O
ferment    O
sugars    O
.    O

FPP    O
is    O
used    O
to    O
form    O
several    O
important    O
classes    O
of    O
compounds    O
in    O
addition    O
to    O
sterols    O
(    O
"    O
via    O
"    O
squalene    O
)    O
,    O
including    O
ubiquinone    B-Antioxidant114724645
and    O
dolichols    O
.    O

Important    O
nonsterol    O
products    O
include    O
ubiquinone    B-Antioxidant114724645
,    O
dolichols    O
,    O
heme    O
A    O
,    O
and    O
farnesylated    O
proteins    O

Because    O
this    O
enzyme    O
catalyzes    O
the    O
formation    O
of    O
precursors    O
far    O
upstream    O
of    O
(    O
S)-2,3-epoxysqualene    O
and    O
cholesterol    O
,    O
statins    O
may    O
negatively    O
influence    O
amounts    O
of    O
intermediates    O
required    O
for    O
other    O
biosynthetic    O
pathways    O
(    O
e.g.    O
synthesis    O
of    O
isoprenoids    O
,    O
coenzyme    B-Antioxidant114724645
Q    I-Antioxidant114724645
)    O
.    O

There    O
is    O
some    O
evidence    O
for    O
the    O
benefits    O
of    O
coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
in    O
treating    O
heart    O
failure    O
.    O

It    O
is    O
the    O
first    O
of    O
two    O
stages    O
in    O
reducing    O
the    O
supplementary    O
form    O
of    O
CoQ10    O
ubiquinone    B-Antioxidant114724645
to    O
the    O
active    O
form    O
ubiquinol    B-Antioxidant114724645
.    O

"    O
Legionella    O
"    O
organisms’    O
dependence    O
on    O
L    O
-    O
cysteine    O
and    O
their    O
unique    O
fatty    O
acids    O
and    O
isoprenoid    O
ubiquinone    B-Antioxidant114724645
distinguish    O
them    O
from    O
other    O
aerobic    O
bacteria    O
.    O

Coenzyme    B-Antioxidant114724645
Q    I-Antioxidant114724645
and    O
vitamin    O
supplements    O
,    O
typically    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
vitamin    O
E    O
,    O
and    O
other    O
antioxidant    O
therapies    O
have    O
been    O
suggested    O
to    O
treat    O
heroin    O
-    O
induced    O
leukoencephalopathy    O
patients    O
.    O

It    O
is    O
also    O
promoted    O
commercially    O
as    O
a    O
synthetic    O
analog    O
of    O
coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
(    O
CoQ10    O
)    O
.    O

Methylation    O
is    O
also    O
required    O
for    O
the    O
biosynthesis    O
of    O
melatonin    O
and    O
the    O
electron    O
transport    O
chain    O
constituent    O
coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
.    O

The    O
pathway    O
produces    O
two    O
five    O
-    O
carbon    O
building    O
blocks    O
called    O
isopentenyl    O
pyrophosphate    O
(    O
IPP    O
)    O
and    O
dimethylallyl    O
pyrophosphate    O
(    O
DMAPP    O
)    O
,    O
which    O
are    O
used    O
to    O
make    O
isoprenoids    O
,    O
a    O
diverse    O
class    O
of    O
over    O
30,000    O
biomolecules    O
such    O
as    O
cholesterol    O
,    O
heme    O
,    O
vitamin    O
K    O
,    O
coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
,    O
and    O
all    O
steroid    O
hormones    O
.    O

It    O
is    O
very    O
structurally    O
similar    O
to    O
ubiquinone    O
,    O
or    O
Coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
,    O
differing    O
by    O
the    O
length    O
of    O
the    O
isoprenyl    O
side    O
chain    O
,    O
replacement    O
of    O
the    O
methoxy    O
groups    O
with    O
methyl    O
groups    O
,    O
and    O
removal    O
of    O
the    O
methyl    O
group    O
in    O
the    O
2    O
position    O
on    O
the    O
quinone    O
.    O

The    O
SDHC    O
/    O
SDHD    O
dimer    O
provides    O
binding    O
sites    O
for    O
ubiquinone    B-Antioxidant114724645
and    O
water    O
during    O
electron    O
transport    O
at    O
Complex    O
II    O
.    O

The    O
electrons    O
are    O
then    O
transferred    O
to    O
an    O
awaiting    O
ubiquinone    B-Antioxidant114724645
molecule    O
at    O
the    O
active    O
site    O
in    O
the    O
SDHC    O
/    O
SDHD    O
dimer    O
.    O

The    O
SDHC    O
/    O
SDHD    O
dimer    O
provides    O
binding    O
sites    O
for    O
ubiquinone    B-Antioxidant114724645
and    O
water    O
during    O
electron    O
transport    O
at    O
Complex    O
II    O
.    O

The    O
electrons    O
are    O
then    O
transferred    O
to    O
an    O
awaiting    O
ubiquinone    B-Antioxidant114724645
molecule    O
at    O
the    O
Q    O
pool    O
active    O
site    O
in    O
the    O
SDHC    O
/    O
SDHD    O
dimer    O
.    O

A    O
variety    O
of    O
disorders    O
can    O
be    O
caused    O
by    O
nuclear    O
mutations    O
of    O
oxidative    O
phosphorylation    O
enzymes    O
,    O
such    O
as    O
coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
deficiency    O
and    O
Barth    O
syndrome    O
.    O

This    O
enzyme    O
participates    O
in    O
ubiquinone    B-Antioxidant114724645
biosynthesis    I-Antioxidant114724645
.    O

This    O
enzyme    O
participates    O
in    O
ubiquinone    B-Antioxidant114724645
biosynthesis    I-Antioxidant114724645
.    O

Agents    O
currently    O
under    O
investigation    O
include    O
anti    O
-    O
apoptotics    O
(    O
omigapil    O
,    O
CEP-1347    O
)    O
,    O
antiglutamatergics    O
,    O
monoamine    O
oxidase    O
inhibitors    O
(    O
selegiline    O
,    O
rasagiline    O
)    O
,    O
promitochondrials    O
(    O
coenzyme    B-Antioxidant114724645
Q10    I-Antioxidant114724645
,    O
creatine    O
)    O
,    O
calcium    O
channel    O
blockers    O
(    O
isradipine    O
)    O
and    O
growth    O
factors    O
(    O
GDNF    O
)    O
.    O

The    O
apicoplast    O
is    O
also    O
thought    O
to    O
have    O
a    O
role    O
in    O
isoprenoid    O
synthesis    O
,    O
which    O
are    O
prosthetic    O
groups    O
on    O
many    O
enzymes    O
and    O
also    O
act    O
as    O
precursors    O
to    O
ubiquinone    B-Antioxidant114724645
(    O
involved    O
in    O
electron    O
transport    O
)    O
and    O
dolichols    O
(    O
involved    O
in    O
glycoprotein    O
formation    O
)    O
.    O

Geranyltranstransferases    O
are    O
an    O
evolutionarily    O
conserved    O
class    O
of    O
enzymes    O
in    O
Archaea    O
,    O
Bacteria    O
,    O
and    O
Eukarya    O
that    O
participate    O
in    O
a    O
broad    O
range    O
of    O
biosynthetic    O
pathways    O
including    O
those    O
of    O
cholesterol    O
,    O
porphyrin    O
,    O
carotenoids    O
,    O
ubiquinone    B-Antioxidant114724645
,    O
and    O
isoprenoids    O
.    O

Ubiquinone    B-Antioxidant114724645
is    O
a    O
key    O
electron    O
carrier    O
in    O
the    O
electron    O
transport    O
chain    O
of    O
cellular    O
respiration    O
.    O

Bis-desmethoxycurcumin    B-Antioxidant114724645

Crocin    B-Antioxidant114724645
(    O
analgesics    O
and    O
respiratory    O
tract    O
)    O

According    O
to    O
a    O
new    O
study    O
,    O
crocin    B-Antioxidant114724645
has    O
demonstrated    O
the    O
properties    O
of    O
an    O
aphrodisiac    O
in    O
rats    O
.    O

Catechin    O
monomer    O
structures    O
are    O
metabolized    O
into    O
dimers    O
theaflavin    B-Antioxidant114724645
and    O
oligomers    O
thearubigins    O
with    O
increasing    O
degrees    O
of    O
oxidation    O
of    O
tea    O
leaves    O
.    O

Darjeeling    O
black    O
tea    O
infusion    O
:    O
Finer    O
black    O
tea    O
has    O
a    O
more    O
orange    O
tone    O
than    O
red    O
as    O
a    O
result    O
of    O
higher    O
theaflavin    B-Antioxidant114724645
content    O
.    O

These    O
include    O
puberulic    O
acid    O
,    O
stipitatonic    O
acid    O
,    O
stipitatic    O
acid    O
,    O
puberulonic    O
acid    O
,    O
sepedonin    O
,    O
and    O
theaflavin    B-Antioxidant114724645
of    O
black    O
tea    O
.    O

MitoQ    B-Antioxidant114724645
,    O
resveratrol    O
and    O
pterostilbene    B-Antioxidant114724645
are    O
dietary    O
supplements    O
that    O
have    O
also    O
been    O
studied    O
in    O
this    O
context    O
.    O

ε-Carotene    B-Antioxidant114724645

Glutathione    O
peroxidases    O
:    O
GPX1    O
,    O
GPX2    O
,    O
GPX3    B-Antioxidant114724645
,    O
GPX4    O
,    O
GPX6    B-Antioxidant114724645

Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
is    O
an    O
essential    O
nutrient    O
,    O
usually    O
ingested    O
as    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
.    O

The    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
-    O
rich    O
fruit    O
are    O
1–3    O
cm    O
in    O
diameter    O
and    O
yellow    O
in    O
color    O
when    O
fully    O
ripe    O
.    O

Ascorbic    B-Antioxidant114724645
Acid    I-Antioxidant114724645
15.5    O
mg    O

Ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
may    O
be    O
protective    O
against    O
CIN    O
,    O
according    O
to    O
a    O
systematic    O
review    O
of    O
randomized    O
controlled    O
trials    O
.    O

Contains    O
alkaloids    O
,    O
carotene    O
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
proteins    O
.    O

Coenzyme    B-Antioxidant114724645
Q    I-Antioxidant114724645
and    O
vitamin    O
supplements    O
,    O
typically    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
vitamin    O
E    O
,    O
and    O
other    O
antioxidant    O
therapies    O
have    O
been    O
suggested    O
to    O
treat    O
heroin    O
-    O
induced    O
leukoencephalopathy    O
patients    O
.    O

The    O
succulent    O
leaves    O
are    O
high    O
in    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
were    O
used    O
by    O
sailors    O
in    O
the    O
past    O
as    O
a    O
scurvy    O
preventative    O
.    O

Its    O
leaves    O
have    O
a    O
salty    O
acid    O
taste    O
and    O
are    O
high    O
in    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
so    O
were    O
used    O
by    O
sailors    O
to    O
prevent    O
scurvy    O
.    O

Ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645

GLUT1    O
is    O
also    O
a    O
major    O
receptor    O
for    O
uptake    O
of    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
as    O
well    O
as    O
glucose    O
,    O
especially    O
in    O
non    O
vitamin    O
C    O
producing    O
mammals    O
as    O
part    O
of    O
an    O
adaptation    O
to    O
compensate    O
by    O
participating    O
in    O
a    O
Vitamin    O
C    O
recycling    O
process    O
.    O

Typical    O
of    O
leaf    O
vegetables    O
,    O
Malabar    O
spinach    O
is    O
high    O
in    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
iron    O
,    O
and    O
calcium    O
.    O

Vitamin    O
C    O
(    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
)    O
is    O
also    O
a    O
required    O
cofactor    O
for    O
the    O
Dopamine    O
beta    O
hydroxylase    O
enzyme    O
.    O

Acetaminophen    O
,    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
,    O
heroin    O
,    O
lactose    O
,    O
mannitol    O
,    O
morphine    O
,    O
and    O
sucrose    O
all    O
cause    O
an    O
instant    O
colour    O
change    O
to    O
purple    O
,    O
as    O
do    O
other    O
compounds    O
with    O
phenol    O
and    O
hydroxyl    O
groups    O
.    O

In    O
2008    O
,    O
the    O
company    O
introduced    O
its    O
next    O
brand    O
extension    O
,    O
five    O
flavors    O
of    O
a    O
soda    O
supplemented    O
with    O
30%    O
USRDA    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
10%    O
vitamin    O
B6    O
and    O
niacin    O
.    O

UDP    O
glucuronic    O
acid    O
is    O
a    O
sugar    O
used    O
in    O
the    O
creation    O
of    O
polysaccharides    O
and    O
is    O
an    O
intermediate    O
in    O
the    O
biosynthesis    O
of    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
except    O
in    O
primates    O
and    O
guinea    O
pigs    O
)    O
.    O

Forced    O
acid    O
diuresis    O
(    O
e.g.    O
,    O
with    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O
will    O
increase    O
methamphetamine    O
excretion    O
but    O
is    O
not    O
recommended    O
as    O
it    O
may    O
increase    O
the    O
risk    O
of    O
aggravating    O
acidosis    O
,    O
or    O
cause    O
seizures    O
or    O
rhabdomyolysis    O
.    O

These    O
are    O
often    O
the    O
three    O
vitamins    O
,    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
vitamin    O
E    O
and    O
polyphenol    O
antioxidants    O
.    O

Other    O
organic    O
compounds    O
produced    O
with    O
hydrochloric    O
acid    O
include    O
bisphenol    O
A    O
for    O
polycarbonate    O
,    O
activated    O
carbon    O
,    O
and    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
,    O
as    O
well    O
as    O
numerous    O
pharmaceutical    O
products    O
.    O

The    O
commercial    O
production    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
)    O
often    O
begins    O
with    O
sorbose    O
.    O

Other    O
supplements    O
may    O
also    O
be    O
needed    O
,    O
including    O
:    O
cobalamin    O
,    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
,    O
folic    O
acid    O
,    O
nicotinamide    O
,    O
zinc    O
,    O
phosphorus    O
(    O
dicalcium    O
phosphate    O
)    O
and    O
in    O
some    O
cases    O
taurine    O
,    O
especially    O
suitable    O
when    O
there    O
cardiocirculatory    O
impairment    O
.    O

Many    O
multivitamin    O
"    O
formulas    O
"    O
contain    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
B1    O
,    O
B2    O
,    O
B3    O
,    O
B5    O
,    O
B6    O
,    O
B9    O
,    O
B12    O
,    O
biotin    O
,    O
A    B-Antioxidant114724645
,    O
E    O
,    O
D2    O
(    O
or    O
D3    O
)    O
,    O
K    O
,    O
potassium    O
,    O
iodine    O
,    O
selenium    O
,    O
borate    O
,    O
zinc    O
,    O
calcium    O
,    O
magnesium    O
,    O
manganese    O
,    O
molybdenum    O
,    O
betacarotene    O
,    O
and/or    O
iron    O
.    O

Rani    O
Juice    O
has    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
other    O
things    O
like    O
protein    O
and    O
calcium    O
.    O

Full    O
skin    O
care    O
ranges    O
(    O
including    O
Tea    O
tree    O
,    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
Vitamin    O
E    O
,    O
Aloe    O
vera    O
and    O
Seaweed    O
)    O

Redoxon    O
is    O
the    O
name    O
of    O
the    O
first    O
artificially    O
synthesized    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O
.    O

A    B-Antioxidant114724645
,    O
D3    O
,    O
E    O
,    O
B6    O
,    O
B12    O
,    O
folic    O
acid    O
(    O
B9    O
)    O
,    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
vitamin    O
C    O
)    O
,    O
along    O
with    O
a    O
vitamin    O
K    O
derivative    O
,    O
menadione    O
sodium    O
bisulfite    O
DVL    O
adds    O
these    O
vitamins    O
to    O
an    O
electrolyte    O
premix    O
that    O
has    O
7    O
mineral    O
salts    O
:    O
magnesium    O
acetate    O
,    O
sodium    O
acetate    O
,    O
calcium    O
acetate    O
,    O
potassium    O
chloride    O
,    O
calcium    O
chloride    O
,    O
sodium    O
chloride    O
and    O
sodium    O
diacetate    O
.    O

The    O
fresh    O
shoots    O
of    O
many    O
spruces    O
and    O
pines    O
are    O
a    O
natural    O
source    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
European    O
sailors    O
adopted    O
the    O
practice    O
and    O
spread    O
it    O
across    O
the    O
world    O
.    O

Innis    O
&    O
None    O
-    O
Alcohol    O
free    O
pale    O
ale    O
with    O
added    O
ginseng    O
and    O
vitamin    B-Antioxidant114724645
c    I-Antioxidant114724645

Therapy    O
with    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
and    O
methylene    O
blue    O
are    O
frequently    O
used    O
in    O
the    O
treatment    O
of    O
methemoglobinemia    O
.    O

It    O
also    O
boasts    O
a    O
higher    O
calcium    O
and    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O
content    O
than    O
lemons    O
.    O

Ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
deficiency    O

It    O
employs    O
one    O
cofactor    O
,    O
ascorbate    B-Antioxidant114724645
.    O

The    O
fruit    O
is    O
an    O
oblong    O
red    O
berry    O
long    O
and    O
broad    O
,    O
ripening    O
in    O
late    O
summer    O
or    O
autumn    O
;    O
they    O
are    O
edible    O
but    O
very    O
sour    O
,    O
and    O
rich    O
in    O
Vitamin    O
C    B-Antioxidant114724645

The    O
berries    O
are    O
edible    O
and    O
rich    O
in    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
though    O
with    O
a    O
very    O
sharp    O
flavor    O
;    O
the    O
thorny    O
shrubs    O
make    O
harvesting    O
them    O
difficult    O
,    O
so    O
in    O
most    O
places    O
,    O
they    O
are    O
not    O
widely    O
consumed    O
.    O

Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
can    O
cause    O
analytical    O
false    O
negatives    O
due    O
to    O
its    O
anti    O
-    O
oxidant    O
properties    O
inhibiting    O
the    O
color    O
reaction    O
.    O

Rohmer    O
was    O
a    O
pioneer    O
in    O
research    O
into    O
prematurity    O
,    O
poliomyelitis    O
,    O
tuberculosis    O
,    O
osteomalacia    O
and    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
He    O
was    O
the    O
director    O
of    O
the    O
pediatric    O
clinic    O
of    O
Strasbourg    O
until    O
his    O
retirement    O
in    O
1947    O
,    O
and    O
made    O
it    O
famous    O
all    O
around    O
Europe    O
.    O

A    O
common    O
pathological    O
disorder    O
concerning    O
the    O
"    O
tunica    O
externa    O
"    O
is    O
scurvy    O
,    O
also    O
known    O
as    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
deficiency    O
.    O

Ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
is    O
an    O
example    O
of    O
this    O
effect    O
.    O

The    O
fruits    O
,    O
sour    O
and    O
rich    O
in    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
can    O
be    O
eaten    O
raw    O
or    O
cooked    O
into    O
a    O
sauce    O
to    O
serve    O
with    O
meat    O
or    O
game    O
.    O

Scurvy    O
(    O
lack    O
of    O
dietary    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O

Maurice    O
Stacey    O
,    O
Professor    O
of    O
Chemistry    O
,    O
worked    O
alongside    O
Sir    O
Norman    O
Haworth    O
to    O
artificially    O
synthesize    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
awarded    O
the    O
1933    O
Meldola    O
Medal    O
of    O
the    O
Royal    O
Society    O
of    O
Chemistry    O
(    O
BSc    O
,    O
PhD    O
,    O
DSc    O
)    O

A    O
typical    O
serving    O
of    O
avocado    O
(    O
100    O
g    O
)    O
is    O
moderate    O
to    O
rich    O
in    O
several    O
B    O
vitamins    O
and    O
vitamin    O
K    O
,    O
with    O
good    O
content    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
vitamin    O
E    O
and    O
potassium    O
(    O
right    O
table    O
,    O
USDA    O
nutrient    O
data    O
)    O
.    O

Scurvy    O
(    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
deficiency    O
)    O
affected    O
the    O
crew    O
.    O

It    O
was    O
burnt    O
due    O
to    O
its    O
inability    O
to    O
maneuver    O
,    O
as    O
a    O
result    O
of    O
the    O
reduced    O
number    O
of    O
the    O
crew    O
as    O
a    O
result    O
of    O
diseases    O
which    O
killed    O
about    O
half    O
the    O
crew    O
,    O
such    O
as    O
scurvy    O
(    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
deficiency    O
)    O
,    O
which    O
was    O
felt    O
acutely    O
while    O
crossing    O
the    O
Indian    O
Ocean    O
.    O

Both    O
lowering    O
the    O
temperature    O
and    O
the    O
addition    O
of    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
seem    O
to    O
prevent    O
oxidation    O
.    O

However    O
,    O
two    O
closely    O
related    O
rat    O
/    O
human    O
members    O
of    O
the    O
family    O
,    O
SVCT1    O
and    O
SVCT2    O
,    O
localized    O
to    O
different    O
tissues    O
of    O
the    O
body    O
,    O
co    O
-    O
transport    O
L    O
-    O
ascorbate    O
(    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O
and    O
Na+    O
with    O
a    O
high    O
degree    O
of    O
specificity    O
and    O
high    O
affinity    O
for    O
the    O
vitamin    O
.    O

Leaves    O
are    O
particularly    O
rich    O
in    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
vitamin    O
K    O
,    O
with    O
moderate    O
content    O
of    O
dietary    O
minerals    O
.    O

Also    O
,    O
regucalcin    O
/    O
SMP30-knockout    O
mice    O
are    O
known    O
to    O
induce    O
a    O
suppression    O
in    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
biosynthesis    O
.    O

Vitamin    O
B12    O
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
thiamin    O

The    O
more    O
knowledgeable    O
also    O
brought    O
dried    O
fruit    O
and    O
vegetables    O
to    O
provide    O
some    O
variety    O
(    O
and    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O
and    O
were    O
a    O
known    O
(    O
to    O
many    O
)    O
scurvy    O
prevention    O
.    O

A    O
known    O
scurvy    O
prevention    O
,    O
as    O
worked    O
out    O
by    O
most    O
navies    O
in    O
the    O
18th    O
century    O
,    O
was    O
found    O
in    O
a    O
diet    O
that    O
contained    O
dried    O
and    O
fresh    O
fruit    O
or    O
vegetables    O
(    O
as    O
finally    O
discovered    O
in    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
rich    O
foods    O
)    O
.    O

Berocca    O
is    O
a    O
brand    O
of    O
effervescent    O
drink    O
and    O
vitamin    O
tablets    O
containing    O
B    O
vitamins    O
and    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
aspartame    O
(    O
phenylalanine    O
)    O
.    O

The    O
leaves    O
contain    O
protein    O
,    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
and    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645

Raw    O
yam    O
has    O
only    O
moderate    O
nutrient    O
density    O
,    O
with    O
appreciable    O
content    O
(    O
10%    O
or    O
more    O
of    O
the    O
Daily    O
Value    O
,    O
DV    O
)    O
limited    O
to    O
potassium    O
,    O
vitamin    O
B6    O
,    O
manganese    O
,    O
thiamin    O
,    O
dietary    O
fiber    O
,    O
and    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
table    O
)    O
.    O

In    O
the    O
past    O
incarnation    O
,    O
the    O
product    O
had    O
only    O
5    O
calories    O
,    O
was    O
sweetened    O
with    O
sucralose    O
,    O
and    O
contained    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
in    O
the    O
form    O
of    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
.    O
in    O
February    O
or    O
March    O
of    O
2016    O
,    O
Fizzies    O
was    O
again    O
discontinued    O
.    O

Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
was    O
isolated    O
by    O
C.C.    O
King    O
at    O
the    O
University    O
of    O
Pittsburgh    O
.    O

Alaska    O
Natives    O
consumed    O
it    O
in    O
bread    O
and    O
pies    O
as    O
a    O
source    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
the    O
Coeur    O
d'Alene    O
people    O
ate    O
the    O
fruit    O
fresh    O
,    O
dried    O
,    O
mashed    O
,    O
cooked    O
,    O
and    O
added    O
it    O
to    O
soup    O
or    O
froze    O
it    O
for    O
later    O
use    O
,    O
and    O
many    O
other    O
groups    O
relished    O
it    O
and    O
stored    O
it    O
frozen    O
,    O
dried    O
,    O
pressed    O
into    O
cakes    O
,    O
or    O
canned    O
for    O
winter    O
use    O
.    O

It    O
was    O
long    O
believed    O
that    O
the    O
men    O
had    O
died    O
from    O
scurvy    O
;    O
an    O
ailment    O
caused    O
by    O
lack    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
and    O
common    O
in    O
polar    O
regions    O
.    O

For    O
example    O
,    O
Jerry    O
Coyne    O
asks    O
why    O
a    O
designer    O
would    O
"    O
give    O
us    O
a    O
pathway    O
for    O
making    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
but    O
then    O
destroy    O
it    O
by    O
disabling    O
one    O
of    O
its    O
enzymes    O
"    O
(    O
see    O
pseudogene    O
)    O
and    O
why    O
a    O
designer    O
would    O
not    O
"    O
stock    O
oceanic    O
islands    O
with    O
reptiles    O
,    O
mammals    O
,    O
amphibians    O
,    O
and    O
freshwater    O
fish    O
,    O
despite    O
the    O
suitability    O
of    O
such    O
islands    O
for    O
these    O
species    O
"    O
.    O

Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
is    O
sometimes    O
added    O
by    O
fortification    O
,    O
because    O
content    O
is    O
variable    O
,    O
and    O
much    O
of    O
that    O
is    O
lost    O
in    O
processing    O
.    O

According    O
to    O
Canadian    O
Food    O
and    O
Drug    O
Regulation    O
,    O
apple    O
juice    O
may    O
contain    O
a    O
Class    O
II    O
preservative    O
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
amylase    O
,    O
cellulase    O
and    O
pectinase    O
.    O

The    O
onion    O
is    O
rich    O
in    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
was    O
important    O
because    O
of    O
this    O
,    O
and    O
it    O
was    O
widely    O
used    O
as    O
medicinal    O
herb    O
against    O
colds    O
and    O
other    O
infections    O
.    O

Albert    O
Szent    O
-    O
Györgyi    O
,    O
discovered    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
1932    O
)    O

It    O
studies    O
the    O
use    O
of    O
statin    O
(    O
simvastatin    O
40    O
mg    O
)    O
medication    O
and    O
vitamin    O
supplementation    O
(    O
vitamin    O
E    O
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
beta    O
carotene    O
)    O
in    O
patients    O
that    O
are    O
at    O
risk    O
for    O
cardiovascular    O
disease    O
.    O

In    O
a    O
100    O
gram    O
amount    O
,    O
raw    O
tomatoes    O
supply    O
18    O
calories    O
and    O
are    O
a    O
moderate    O
source    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
17%    O
of    O
the    O
Daily    O
Value    O
)    O
,    O
but    O
otherwise    O
are    O
absent    O
of    O
significant    O
nutrient    O
content    O
(    O
table    O
)    O
.    O

Additionally    O
,    O
such    O
a    O
value    O
does    O
not    O
highlight    O
prevalence    O
in    O
types    O
of    O
antioxidants    O
compounds    O
over    O
others    O
(    O
like    O
lycopene    O
versus    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
)    O
,    O
meaning    O
that    O
while    O
a    O
resulting    O
content    O
value    O
between    O
two    O
substances    O
may    O
be    O
similar    O
,    O
though    O
the    O
potential    O
overlying    O
resulting    O
effect    O
can    O
differ    O
,    O
making    O
clinical    O
assessments    O
of    O
resulting    O
symptoms    O
highly    O
unreliable    O
as    O
to    O
the    O
underlying    O
condition    O
.    O

Development    O
of    O
technology    O
for    O
the    O
production    O
of    O
vitamins    O
A1    O
,    O
B1    O
,    O
B2    O
,    O
E    O
,    O
C    B-Antioxidant114724645
and    O
K1    O
;    O

Antioxidants    O
,    O
such    O
as    O
vitamins    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
E    O
,    O
have    O
been    O
proposed    O
to    O
protect    O
against    O
the    O
disease    O
,    O
but    O
results    O
of    O
studies    O
have    O
been    O
contradictory    O
and    O
no    O
positive    O
effect    O
has    O
been    O
proven    O
.    O

|rowspan=2|    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
Ascorbic    O
acid    O
)    O

However    O
none    O
of    O
these    O
herbs    O
are    O
rich    O
in    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
the    O
usual    O
preparation    O
by    O
extracting    O
of    O
juices    O
would    O
have    O
destroyed    O
most    O
of    O
their    O
content    O
,    O
rendering    O
the    O
preparations    O
ineffectual    O
against    O
true    O
scurvy    O
.    O

Vitamins    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
C    B-Antioxidant114724645
and    O
E    O
have    O
been    O
shown    O
to    O
be    O
'    O
free    O
radical    O
scavengers    O
'    O
by    O
studies    O
looking    O
for    O
protective    O
tendencies    O
of    O
antioxidants    O
.    O

Other    O
vitamins    O
to    O
be    O
taken    O
by    O
HIV    O
-    O
infected    O
adults    O
are    O
vitamins    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
E.    O

Usually    O
all    O
15    O
nutrients    O
are    O
shown    O
:    O
calories    O
,    O
calories    O
from    O
fat    O
,    O
fat    O
,    O
saturated    O
fat    O
,    O
trans    O
fat    O
,    O
cholesterol    O
,    O
sodium    O
,    O
carbohydrates    O
,    O
dietary    O
fiber    O
,    O
sugars    O
,    O
protein    O
,    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
calcium    O
,    O
and    O
iron    O
.    O

Specifically    O
,    O
blueberries    O
,    O
as    O
a    O
popular    O
superfood    O
example    O
,    O
are    O
not    O
especially    O
nutrient    O
-    O
dense    O
(    O
considered    O
to    O
be    O
a    O
superfood    O
characteristic    O
)    O
,    O
having    O
moderate    O
content    O
of    O
only    O
three    O
essential    O
nutrients    O
:    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
an    O
antioxidant    O
)    O
,    O
vitamin    O
K    O
and    O
manganese    O
.    O

The    O
soldiers    O
suffered    O
widespread    O
scurvy    O
(    O
due    O
to    O
poor    O
nutrition    O
and    O
lack    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O
,    O
which    O
claimed    O
the    O
lives    O
of    O
over    O
200    O
of    O
the    O
1,120    O
men    O
that    O
first    O
winter    O
.    O

an    O
excellent    O
source    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
50%    O
)    O
or    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
(    O
25%    O
)    O
or    O
folate    O
(    O
25%    O
)    O
or    O
source    O
of    O
fibre    O
(    O
2    O
grams    O
)    O

His    O
evidence    O
for    O
this    O
is    O
a    O
chart    O
based    O
on    O
references    O
for    O
1963    O
and    O
2008    O
which    O
shows    O
values    O
of    O
beta    O
-    O
carotene    O
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
iron    O
found    O
in    O
spinach    O
and    O
carrot    O
,    O
from    O
which    O
he    O
appears    O
to    O
infer    O
a    O
comparable    O
enzyme    O
deficit    O
in    O
all    O
vegetable    O
food    O
sources    O
.    O

In    O
1920    O
she    O
held    O
a    O
temporary    O
post    O
investigating    O
the    O
nutrition    O
,    O
specifically    O
the    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
content    O
,    O
of    O
mine    O
workers    O
'    O
diets    O
in    O
the    O
area    O
of    O
Johannesburg    O
,    O
and    O
as    O
a    O
result    O
"    O
their    O
health    O
was    O
substantially    O
improved    O
"    O
.    O

To    O
avoid    O
this    O
,    O
local    O
spruce    O
beer    O
began    O
to    O
be    O
used    O
to    O
supplement    O
the    O
rations    O
with    O
additional    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
Spruce    O
beer    O
was    O
not    O
consistently    O
used    O
,    O
however    O
,    O
but    O
primarily    O
in    O
reaction    O
to    O
occurrences    O
of    O
scurvy    O
.    O

In    O
the    O
first    O
step    O
of    O
this    O
pathway    O
,    O
H2O2    O
is    O
reduced    O
to    O
water    O
by    O
ascorbate    B-Antioxidant114724645
peroxidase    I-Antioxidant114724645
(    O
APX    O
)    O
using    O
ascorbate    B-Antioxidant114724645
as    O
the    O
electron    O
donor    O
.    O

Thus    O
ascorbate    B-Antioxidant114724645
and    O
glutathione    B-Antioxidant114724645
are    O
not    O
consumed    O
;    O
the    O
net    O
electron    O
flow    O
is    O
from    O
NADPH    O
to    O
H2O2    O
.    O

The    O
tomatoes    O
are    O
high    O
in    O
lycopene    O
,    O
antioxidants    O
,    O
and    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
The    O
final    O
products    O
may    O
contain    O
up    O
to    O
2–6%    O
of    O
salt    O
and    O
could    O
provide    O
a    O
significant    O
contribution    O
to    O
the    O
day    O
's    O
intake    O
.    O

This    O
squash    O
is    O
rich    O
in    O
beta    O
carotene    O
,    O
with    O
iron    O
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
potassium    O
,    O
and    O
smaller    O
traces    O
of    O
calcium    O
,    O
folic    O
acid    O
,    O
and    O
minute    O
amounts    O
of    O
B    O
vitamins    O
.    O

In    O
a    O
100    O
gram    O
amount    O
,    O
elderberries    O
supply    O
73    O
calories    O
and    O
are    O
a    O
rich    O
source    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
providing    O
43%    O
of    O
the    O
Daily    O
Value    O
(    O
DV    O
)    O
.    O

Individual    O
fruits    O
weigh    O
between    O
270    O
and    O
480    O
mg    O
and    O
contain    O
high    O
amounts    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
vitamin    O
E    O
,    O
carotenoids    O
,    O
flavonoids    O
and    O
health    O
-    O
beneficial    O
fatty    O
acids    O
,    O
as    O
well    O
as    O
higher    O
amounts    O
of    O
vitamin    O
B12    O
than    O
other    O
fruits    O
.    O

The    O
fruit    O
of    O
the    O
plant    O
has    O
a    O
high    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
content    O
–    O
in    O
a    O
range    O
of    O
114    O
to    O
1550    O
mg    O
per    O
100    O
grams    O
with    O
an    O
average    O
content    O
(    O
695    O
mg    O
per    O
100    O
grams    O
)    O
,    O
placing    O
sea    O
buckthorn    O
fruit    O
among    O
the    O
most    O
enriched    O
plant    O
sources    O
of    O
vitamin    O
C.    O

It    O
was    O
found    O
that    O
when    O
chromium    O
(    O
VI    O
)    O
species    O
formed    O
under    O
physiological    O
conditions    O
,    O
they    O
were    O
reduced    O
by    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
glutathione    B-Antioxidant114724645
to    O
form    O
reactive    O
intermediate    O
complexes    O
.    O

Rice    O
water    O
has    O
vitamin    O
B    O
,    O
C    B-Antioxidant114724645
,    O
E    O
,    O
and    O
minerals    O
,    O
which    O
help    O
in    O
tightening    O
skin    O
and    O
shrinkage    O
of    O
open    O
pores    O
on    O
face    O
.    O

Albert    O
Szent    O
-    O
Györgyi    O
isolated    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
around    O
1930    O

Albert    O
Szent    O
-    O
Györgyi    O
discovered    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
created    O
the    O
first    O
artificial    O
vitamin    O
.    O

Albert    O
Szent    O
-    O
Györgyi    O
a    O
Nobel    O
Laureate    O
in    O
Medicine    O
for    O
discover    O
of    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645

When    O
cultured    O
in    O
a    O
“    O
promineralization    O
medium    O
”    O
that    O
contains    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
known    O
to    O
promote    O
skeletal    O
-    O
like    O
ECM    O
formation    O
in    O
osteoblasts    O
)    O
and    O
a    O
source    O
of    O
phosphate    O
(    O
for    O
hydroxyapatite    O
formation    O
)    O
,    O
C4    O
-    O
2B    O
cells    O
produce    O
and    O
retain    O
approximately    O
8x    O
more    O
mineralized    O
calcium    O
than    O
parental    O
LNCaP    O
cells    O
.    O

Among    O
these    O
materials    O
were    O
sugar    O
and    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
The    O
loss    O
to    O
consumers    O
in    O
watering    O
down    O
procedures    O
has    O
been    O
estimated    O
at    O
$    O
1    O
million    O
in    O
lost    O
value    O
.    O

Valoneic    O
acid    O
dilactone    O
,    O
flavogallonic    O
acid    O
dilactone    O
,    O
gallagyldilactone    O
,    O
ellagic    O
acid    O
and    O
gallic    O
acid    O
are    O
hydrolysable    O
tannins    O
that    O
can    O
be    O
isolated    O
from    O
the    O
heartwood    O
of    O
"    O
S.    O
laeviforia    O
"    O
as    O
well    O
as    O
two    O
stilbenoids    O
,    O
laevifonol    O
(    O
an    O
ε-viniferin    O
-    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
hybrid    O
compound    O
)    O
and    O
laevifoside    O
(    O
an    O
O    O
-    O
glucoside    O
of    O
ampelopsin    O
A    O
)    O
.    O

The    O
predominant    O
type    O
of    O
acerola    O
produced    O
here    O
is    O
the    O
"    O
Olivier    O
"    O
,    O
a    O
variety    O
that    O
is    O
packed    O
with    O
the    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
1.200    O
mg/100ml    O
of    O
juice    O
and    O
1.400    O
mg/100    O
g    O
of    O
pulp    O
)    O
for    O
which    O
this    O
plant    O
is    O
primarily    O
cultivated    O
and    O
can    O
be    O
cultivated    O
with    O
little    O
pesticide    O
.    O

This    O
is    O
the    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
rich    O
fruit    O
for    O
which    O
Junqueirópolis    O
has    O
been    O
nicknamed    O
"    O
Capital    O
da    O
Acerola    O
"    O
,    O
the    O
"    O
Acerola    O
Capital    O
"    O
.    O

Juice    O
from    O
the    O
ripe    O
berries    O
is    O
astringent    O
,    O
sweet    O
(    O
with    O
high    O
sugar    O
content    O
)    O
,    O
sour    O
(    O
low    O
pH    O
)    O
,    O
and    O
contains    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645

Cooked    O
amaranth    O
leaves    O
are    O
an    O
excellent    O
source    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
calcium    O
,    O
manganese    O
,    O
and    O
folate    O
.    O

Ascorbic    O
acid    O
is    O
one    O
form    O
(    O
"    O
vitamer    O
"    O
)    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
It    O
was    O
originally    O
called    O
L    O
-    O
hexuronic    O
acid    O
,    O
but    O
,    O
when    O
it    O
was    O
found    O
to    O
have    O
vitamin    O
C    O
activity    O
in    O
animals    O
(    O
"    O
vitamin    O
C    O
"    O
being    O
defined    O
as    O
a    O
vitamin    O
activity    O
,    O
not    O
then    O
a    O
specific    O
substance    O
)    O
,    O
the    O
suggestion    O
was    O
made    O
to    O
rename    O
it    O
.    O

The    O
newly    O
discovered    O
food    O
-    O
factor    O
was    O
eventually    O
called    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645

Eccrine    O
sweat    O
is    O
clear    O
,    O
odorless    O
,    O
and    O
is    O
composed    O
of    O
98–99%    O
water    O
;    O
it    O
also    O
contains    O
NaCl    O
,    O
fatty    O
acids    O
,    O
lactic    O
acid    O
,    O
citric    O
acid    O
,    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
,    O
urea    O
,    O
and    O
uric    O
acid    O
.    O

From    O
about    O
500    O
million    O
years    O
ago    O
,    O
freshwater    O
and    O
terrestrial    O
plants    O
slowly    O
optimized    O
the    O
production    O
of    O
“    O
new    O
”    O
endogenous    O
antioxidants    O
,    O
such    O
as    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
vitamin    O
C    O
)    O
,    O
natural    O
phenols    O
(    O
including    O
flavonoids    O
)    O
and    O
polyphenols    O
,    O
tocopherols    O
,    O
etc    O
.    O

It    O
has    O
been    O
shown    O
not    O
only    O
that    O
increased    O
levels    O
of    O
protective    O
low    O
molecular    O
weight    O
antioxidants    O
through    O
a    O
diet    O
rich    O
in    O
phytochemicals    O
,    O
but    O
also    O
by    O
direct    O
topical    O
dermal    O
application    O
of    O
low    O
molecular    O
weight    O
antioxidants    O
,    O
notably    O
vitamins    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
E    O
,    O
as    O
well    O
as    O
lipoic    O
acid    O
,    O
may    O
confer    O
protective    O
effects    O
against    O
oxidative    O
stress    O
.    O

Experiments    O
with    O
binary    O
mixtures    O
of    O
natural    O
phenolic    O
antioxidants    O
with    O
a    O
non    O
-    O
phenolic    O
antioxidant    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
show    O
that    O
phenolics    O
exhibit    O
antagonism    O
when    O
combined    O
with    O
this    O
latter    O
compound    O
.    O

He    O
was    O
also    O
an    O
early    O
proponent    O
of    O
low    O
carb    O
dieting    O
,    O
and    O
recommended    O
the    O
use    O
of    O
numerous    O
supplements    O
,    O
including    O
desiccated    O
liver    O
tablets    O
,    O
225mcg    O
kelp    O
tablets    O
,    O
vitamin    B-Antioxidant114724645
c    I-Antioxidant114724645
tablets    O
,    O
digestive    O
enzymes    O
and    O
raw    O
glandulars    O
such    O
as    O
adrenal    O
and    O
orchic    O
.    O

Originally    O
it    O
was    O
reported    O
that    O
early    O
settlers    O
got    O
their    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
intake    O
,    O
and    O
thus    O
avoided    O
scurvy    O
,    O
by    O
eating    O
hawberries    O
.    O

The    O
potato    O
is    O
also    O
a    O
good    O
source    O
of    O
many    O
vitamins    O
and    O
minerals    O
,    O
particularly    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
especially    O
when    O
fresh    O
)    O
.    O

However    O
,    O
other    O
research    O
suggests    O
that    O
scurvy    O
(    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
deficiency    O
)    O
and    O
environmental    O
factors    O
also    O
contributed    O
to    O
their    O
deaths    O
.    O

20%    O
of    O
the    O
RDI    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645

a    O
"    O
good    O
source    O
"    O
(    O
10%    O
of    O
the    O
RDI    O
)    O
of    O
vitamins    O
C    B-Antioxidant114724645
and    O
E.    O

The    O
tea    O
is    O
deep    O
ruby    O
-    O
brown    O
to    O
rich    O
dark    O
maroon    O
in    O
color    O
and    O
is    O
abundant    O
in    O
iron    O
,    O
potassium    O
,    O
and    O
vitamins    O
B    O
and    O
C    B-Antioxidant114724645
It    O
is    O
often    O
garnished    O
with    O
pine    O
nuts    O
.    O

The    O
potato    O
is    O
also    O
a    O
good    O
source    O
of    O
many    O
vitamins    O
and    O
minerals    O
,    O
particularly    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
when    O
fresh    O
.    O

Acetaldehyde    O
is    O
a    O
highly    O
unstable    O
compound    O
and    O
quickly    O
forms    O
free    O
radical    O
structures    O
which    O
are    O
highly    O
toxic    O
if    O
not    O
quenched    O
by    O
antioxidants    O
such    O
as    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
)    O
and    O
Vitamin    O
B1    O
(    O
thiamine    O
)    O
.    O

During    O
the    O
summer    O
months    O
the    O
trees    O
exhibit    O
round    O
to    O
oval    O
fruit    O
,    O
rich    O
in    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
with    O
a    O
thick    O
peel    O
covering    O
white    O
slippery    O
pulp    O
,    O
which    O
like    O
the    O
leaves    O
turns    O
increasingly    O
yellow    O
at    O
the    O
end    O
of    O
the    O
blooming    O
season    O
.    O

Every    O
part    O
of    O
the    O
tree    O
is    O
useful    O
and    O
the    O
fruit    O
in    O
particular    O
is    O
used    O
in    O
Ayurvedic    O
medicinal    O
preparations    O
and    O
is    O
rich    O
in    O
Vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645

Many    O
claims    O
have    O
been    O
made    O
about    O
the    O
beneficial    O
effects    O
of    O
aguapanela    O
,    O
based    O
on    O
beliefs    O
such    O
as    O
having    O
more    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
than    O
orange    O
juice    O
or    O
as    O
many    O
rehydrating    O
minerals    O
as    O
Gatorade    O
.    O

Myrosinase    O
is    O
activated    O
by    O
l-ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
vitamin    O
C    O
)    O
under    O
the    O
influence    O
of    O
the    O
pH    O
,    O
and    O
higher    O
myrosinase    O
activity    O
has    O
been    O
shown    O
in    O
damaged    O
cabbage    O
leaves    O
,    O
while    O
its    O
activity    O
is    O
reduced    O
by    O
cooking    O
the    O
leaves    O
,    O
although    O
the    O
glucosinolates    O
can    O
then    O
be    O
transformed    O
to    O
allyl    O
cyanide    O
by    O
microflora    O
in    O
the    O
intestines    O
.    O

Malic    O
acid    O
,    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
,    O
citric    O
acid    O
,    O
ketoglutaric    O
acid    O
,    O
fumaric    O
acid    O
,    O
shikimic    O
acid    O
and    O
traces    O
of    O
succinic    O
acid    O
were    O
detected    O
.    O

Common    O
variants    O
replace    O
part    O
of    O
the    O
shrimp    O
or    O
peas    O
with    O
fish    O
meat    O
,    O
spinach    O
,    O
spirulina    O
,    O
or    O
mussel    O
meat    O
,    O
and    O
add    O
astaxanthin    B-Antioxidant114724645
,    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
,    O
or    O
garlic    O
.    O

Due    O
to    O
the    O
nature    O
of    O
canthaxanthin    O
,    O
relative    O
to    O
astaxanthin    B-Antioxidant114724645
(    O
a    O
carotenoid    O
of    O
significant    O
commercial    O
value    O
)    O
these    O
beta    O
-    O
carotene    O
ketolase    O
proteins    O
have    O
been    O
studied    O
extensively    O
.    O

Canthaxanthin    O
is    O
used    O
in    O
combination    O
with    O
astaxanthin    B-Antioxidant114724645
for    O
some    O
salmon    O
feeds    O
.    O

Astaxanthin    B-Antioxidant114724645
-    O
found    O
naturally    O
in    O
red    O
algae    O
and    O
animals    O
higher    O
in    O
the    O
marine    O
food    O
chain    O
.    O

β-Crustacyanin    O
(    O
β-CR    O
)    O
,    O
is    O
composed    O
of    O
two    O
stacked    O
astaxanthin    B-Antioxidant114724645
carotenoids    O
that    O
absorb    O
at    O
λ    O
=    O
580–590    O
nm    O
(    O
2.10–2.14    O
eV    O
)    O
.    O

Astaxanthin    B-Antioxidant114724645
is    O
the    O
main    O
carotenoid    O
in    O
marine    O
crustaceans    O
(    O
and    O
fish    O
)    O
.    O

Astaxanthin    B-Antioxidant114724645

Rhodoxanthin    B-Antioxidant114724645
is    O
a    O
xanthophyll    O
pigment    O
with    O
a    O
purple    O
color    O
that    O
is    O
found    O
in    O
small    O
quantities    O
in    O
a    O
variety    O
of    O
plants    O
including    O
"    O
Taxus    O
baccata    O
"    O
.    O

Catechins    O
include    O
epigallocatechin-3-gallate    B-Antioxidant114724645
(    O
EGCG    O
)    O
,    O
epicatechin    O
(    O
EC    O
)    O
,    O
epicatechin-3-gallate    O
(    O
ECg    O
)    O
,    O
epigallocatechin    O
(    O
EGC    O
)    O
,    O
catechin    O
,    O
and    O
gallocatechin    O
(    O
GC).The    O
content    O
of    O
EGCG    O
is    O
higher    O
in    O
green    O
tea    O
.    O

Gallic    O
acid    O
conjugates    O
all    O
of    O
the    O
catechins    O
,    O
such    O
as    O
EGCG    O
(    O
Epigallocatechin    B-Antioxidant114724645
gallate    I-Antioxidant114724645
)    O
,    O
which    O
are    O
tannins    O
with    O
astringent    O
qualities    O
.    O

(−)‐Epigallocatechin‐3‐gallate    B-Antioxidant114724645
is    O
one    O
such    O
example    O
of    O
a    O
second    O
-    O
order    O
modulator    O
at    O
GABAA    O
receptors    O
.    O

EGCG    B-Antioxidant114724645
,    O
a    O
polyphenol    O
in    O
green    O
tea    O
,    O
has    O
shown    O
in    O
a    O
study    O
to    O
inhibit    O
EBV    O
spontaneous    O
lytic    O
infection    O
at    O
the    O
DNA    O
,    O
gene    O
transcription    O
and    O
protein    O
levels    O
in    O
a    O
time    O
and    O
dose    O
-    O
dependent    O
manner    O
;    O
the    O
expression    O
of    O
EBV    O
lytic    O
genes    O
Zta    O
,    O
Rta    O
,    O
and    O
early    O
antigen    O
complex    O
EA    O
-    O
D    O
(    O
induced    O
by    O
Rta    O
)    O
,    O
however    O
,    O
the    O
highly    O
stable    O
EBNA-1    O
gene    O
found    O
across    O
all    O
stages    O
of    O
EBV    O
infection    O
is    O
unaffected    O
.    O

Skinny    O
Water    O
(    O
owned    O
by    O
Skinny    O
Nutritional    O
Corp.    O
)    O
and    O
Nutrisoda    O
's    O
Slenderized    O
(    O
owned    O
by    O
PepsiCo    O
)    O
have    O
both    O
used    O
a    O
polyphenol    O
called    O
epigallocatechin    B-Antioxidant114724645
gallate    I-Antioxidant114724645
(    O
EGCG    O
)    O
in    O
their    O
products    O
for    O
their    O
"    O
effect    O
"    O
.    O

Chemical    O
compounds    O
derived    O
from    O
cruciferous    O
vegetables    O
and    O
EGCG    B-Antioxidant114724645
inhibit    O
lung    O
tumorigenesis    O
by    O
NNK    O
in    O
animal    O
models    O
.    O

As    O
part    O
of    O
a    O
larger    O
effort    O
to    O
improve    O
the    O
nutrition    O
of    O
their    O
products    O
,    O
Chick    O
-    O
fil    O
-    O
A    O
announced    O
in    O
late    O
2013    O
it    O
was    O
removing    O
dyes    O
,    O
corn    O
syrup    O
,    O
and    O
TBHQ    B-Antioxidant114724645
from    O
their    O
products    O
.    O

Anoxomer    O
is    O
prepared    O
by    O
condensation    O
polymerization    O
of    O
divinylbenzene    O
and    O
a    O
mixture    O
of    O
antioxidant    O
monomers    O
including    O
"tert"-butylhydroquinone    B-Antioxidant114724645
,    O
"    O
tert    O
"-    O
butylphenol    O
,    O
hydroxyanisole    O
,    O
"    O
p    O
"-    O
cresol    O
and    O
4,4'-isopropylidenediphenol    O
.    O

Piceatannol    B-Antioxidant114724645
the    O
roots    O
of    O
Norway    O
spruces    O

The    O
stilbenolignan    O
aiphanol    O
,    O
isorhapontigenin    O
,    O
piceatannol    B-Antioxidant114724645
and    O
luteolin    O
can    O
be    O
found    O
in    O
the    O
seeds    O
of    O
"    O
Aiphanes    O
aculeata    O
"    O
.    O

Bixin    B-Antioxidant114724645
is    O
an    O
apocarotenoid    O
found    O
in    O
annatto    B-Antioxidant114724645
,    O
a    O
natural    O
food    O
coloring    O
obtained    O
from    O
the    O
seeds    O
of    O
the    O
achiote    B-Antioxidant114724645
tree    I-Antioxidant114724645
(    O
"    O
Bixa    O
orellana    O
"    O
)    O
.    O

Procyanidin    O
B8    O
is    O
a    O
catechin    B-Antioxidant114724645
epicatechin    B-Antioxidant114724645
dimer    O
.    O

It    O
is    O
an    O
epicatechin    B-Antioxidant114724645
catechin    B-Antioxidant114724645
dimer    O
found    O
in    O
"    O
Rhododendron    O
spiciferum    O
"    O
,    O
in    O
peanut    O
skins    O
and    O
in    O
"    O
Ecdysanthera    O
utilis    O
"    O
.    O

"    O
U.    O
guianensis    O
"    O
contains    O
many    O
phytochemicals    O
(    O
(    O
epicatechin    B-Antioxidant114724645
,    O
alkaloid    O
,    O
beta    O
-    O
Sitosterol    O
,    O
campesterol    O
,    O
campherol    O
,    O
catechol    O
,    O
catechutannic    O
acid    O
,    O
chlorogenic    O
acid    O
,    O
ellagic    O
acid    O
,    O
gallic    O
acid    O
,    O
hyperin    O
,    O
oleanolic    O
acid    O
,    O
rutin    O
,    O
stigmasterol    O
,    O
ursolic    O
acid    O
)    O
and    O
proanthocyanidin    O
B1    O
and    O
proanthocyanidin    O
B2    O
,    O
B    O
type    O
proanthocyanidins    O
,    O
in    O
the    O
root    O
.    O

File:(–    O
)    O
-Epicatechin.svg|(–    O
)    O
Epicatechin    B-Antioxidant114724645

Polyphenols    O
found    O
in    O
green    O
tea    O
include    O
but    O
are    O
not    O
limited    O
to    O
epigallocatechin    B-Antioxidant114724645
gallate    I-Antioxidant114724645
(EGCG)    I-Antioxidant114724645
,    O
epigallocatechin    O
,    O
epicatechin    O
gallate    O
,    O
and    O
epicatechin    B-Antioxidant114724645
;    O
flavanol    B-Antioxidant114724645
such    O
as    O
kaempferol    O
,    O
quercetin    O
,    O
and    O
myricitin    O
are    O
also    O
found    O
in    O
green    O
tea    O
.    O

Catechin    B-Antioxidant114724645

These    O
substrates    O
include    O
monochlorophenols    O
,    O
dichlorophenols    O
,    O
and    O
more    O
complex    O
species    O
such    O
as    O
the    O
pesticide    O
2,4,5-T.    O
Hydroxyquinol    O
commonly    O
occurs    O
in    O
nature    O
as    O
a    O
biodegradation    O
product    O
of    O
catechin    B-Antioxidant114724645
,    O
a    O
natural    O
phenol    O
found    O
in    O
plants    O
such    O
as    O
"    O
Bradyrhizobium    O
japonicum    O
"    O
.    O

"    O
B.    O
japonicum    O
"    O
is    O
able    O
to    O
degrade    O
catechin    B-Antioxidant114724645
with    O
formation    O
of    O
phloroglucinol    O
carboxylic    O
acid    O
,    O
further    O
decarboxylated    O
to    O
phloroglucinol    O
,    O
which    O
is    O
dehydroxylated    O
to    O
resorcinol    O
and    O
hydroxyquinol    O
.    O

"    O
Diaporthe    O
"    O
species    O
have    O
been    O
shown    O
to    O
transform    O
the    O
infection    O
-    O
inhibiting    O
factors    O
(    O
+    O
)    O
catechin    B-Antioxidant114724645
and    O
(    O
−)-epicatechin    O
into    O
the    O
3,4-cis    O
-    O
dihydroxyflavan    O
derivatives    O

Leucocyanidin    O
reductase    O
(    O
LCR    O
)    O
uses    O
2,3-trans-3,4-cis    O
-    O
leucocyanidin    O
to    O
produce    O
(    O
+    O
)    O
catechin    B-Antioxidant114724645
and    O
is    O
the    O
first    O
enzyme    O
in    O
the    O
proanthocyanidins    O
(    O
PA)-specific    O
pathway    O
.    O

"    O
C.    O
cupreum    O
"    O
is    O
able    O
to    O
degradae    O
catechin    B-Antioxidant114724645
.    O

The    O
chemical    O
compounds    O
oxyresveratrol    O
,    O
(    O
+    O
)    O
catechin    B-Antioxidant114724645
,    O
afzelechin-3-O    O
-    O
alpha    O
-    O
L    O
-    O
rhamnopyranoside    O
,    O
(    O
−)-epiafzelechin    O
,    O
dihydromorin    O
,    O
epiafzelechin-(4beta→8)-epicatechin    O
,    O
dadahol    O
A    O
and    O
dadahol    O
B    O
,    O
resveratrol    O
,    O
steppogenin    O
,    O
moracin    O
M    O
,    O
isogemichalcone    O
B    O
,    O
gemichalcone    O
B    O
,    O
norartocarpetin    O
and    O
engeletin    O
can    O
be    O
found    O
in    O
"    O
A.    O
dadah    O
"    O
.    O

B    O
-    O
type    O
procyanidin    O
(    O
catechin    B-Antioxidant114724645
dimer    O
)    O
can    O
be    O
converted    O
to    O
A    O
-    O
type    O
procyanidin    O
by    O
radical    O
oxidation    O
.    O

Bergenin    O
,    O
catechin    B-Antioxidant114724645
,    O
gallic    O
acid    O
,    O
gallicin    O
,    O
catechin-7-O    O
-    O
glucoside    O
and    O
β-sitosterol    O
can    O
be    O
found    O
in    O
"    O
B.    O
ciliata    O
"    O
.    O

The    O
catechu    O
extract    O
from    O
"    O
A.    O
catechu    O
"    O
figures    O
in    O
the    O
history    O
of    O
chemistry    O
in    O
giving    O
its    O
name    O
to    O
the    O
catechin    B-Antioxidant114724645
,    O
catechol    O
,    O
and    O
catecholamine    O
chemical    O
families    O
ultimately    O
derived    O
from    O
it    O
.    O

Through    O
derivatives    O
of    O
the    O
flavanol    B-Antioxidant114724645
in    O
its    O
extracts    O
,    O
the    O
species    O
has    O
lent    O
its    O
name    O
to    O
the    O
important    O
catechin    B-Antioxidant114724645
,    O
catechols    O
and    O
catecholamines    O
of    O
chemistry    O
and    O
biology    O
.    O

Catechin    B-Antioxidant114724645

Chebulic    O
acid    O
is    O
a    O
component    O
of    O
transformed    O
ellagitannins    O
such    O
as    O
chebulagic    B-Antioxidant114724645
acid    I-Antioxidant114724645
or    O
chebulinic    O
acid    O
.    O

Mineral    B-Antioxidant114724645
ascorbates    I-Antioxidant114724645
:    O
salts    O
of    O
ascorbic    O
acid    O

Torulene    B-Antioxidant114724645
(    O
3',4'-didehydro-β,γ-carotene    O
)    O
is    O
a    O
carotene    O
(    O
a    O
hydrocarbon    O
carotenoid    O
)    O
which    O
is    O
notable    O
for    O
being    O
synthesized    O
by    O
red    O
pea    O
aphids    O
(    O
"    O
Acyrthosiphon    O
pisum    O
"    O
)    O
,    O
imparting    O
the    O
natural    O
red    O
color    O
to    O
the    O
aphids    O
,    O
which    O
aids    O
in    O
their    O
camouflage    O
and    O
escape    O
from    O
predation    O
.    O

Ascorbate    B-Antioxidant114724645
peroxidase    I-Antioxidant114724645
,    O
an    O
antioxidant    O
enzyme    O
.    O

Rubixanthin    B-Antioxidant114724645
,    O
or    O
natural    B-Antioxidant114724645
yellow    I-Antioxidant114724645
27    I-Antioxidant114724645
,    O
is    O
a    O
natural    O
xanthophyll    O
pigment    O
with    O
a    O
red    O
-    O
orange    O
color    O
found    O
in    O
rose    O
hips    O
.    O

It    O
has    O
been    O
argued    O
that    O
a    O
water    O
molecule    O
(    O
HOH39    O
)    O
arrives    O
at    O
the    O
active    O
site    O
and    O
is    O
coordinated    O
by    O
His207    O
of    O
subunit    O
B    O
,    O
Arg31    O
of    O
subunit    O
C    O
,    O
and    O
Asp82    O
of    O
subunit    O
D.    O
The    O
semiquinone    O
species    O
is    O
protonated    O
by    O
protons    O
delivered    O
from    O
HOH39    O
,    O
completing    O
the    O
ubiquinone    B-Antioxidant114724645
reduction    O
to    O
ubiquinol    B-Antioxidant114724645
.    O
His207    O
and    O
Asp82    O
most    O
likely    O
facilitate    O
this    O
process    O
.    O

The    O
electrons    O
are    O
transferred    O
through    O
a    O
series    O
of    O
iron    O
-    O
sulfur    O
(    O
Fe    O
-    O
S    O
)    O
clusters    O
in    O
the    O
prosthetic    O
arm    O
and    O
finally    O
to    O
coenzyme    O
Q10    O
(    O
CoQ    O
)    O
,    O
which    O
is    O
reduced    O
to    O
ubiquinol    B-Antioxidant114724645
(    O
CoQH2    O
)    O
.    O

The    O
electrons    O
are    O
transferred    O
through    O
a    O
series    O
of    O
iron    O
-    O
sulfur    O
(    O
Fe    O
-    O
S    O
)    O
clusters    O
in    O
the    O
prosthetic    O
arm    O
and    O
finally    O
to    O
coenzyme    O
Q10    O
(    O
CoQ    O
)    O
,    O
which    O
is    O
reduced    O
to    O
ubiquinol    B-Antioxidant114724645
(    O
CoQH2    O
)    O
.    O

It    O
is    O
the    O
first    O
of    O
two    O
stages    O
in    O
reducing    O
the    O
supplementary    O
form    O
of    O
CoQ10    O
ubiquinone    B-Antioxidant114724645
to    O
the    O
active    O
form    O
ubiquinol    B-Antioxidant114724645
.    O

The    O
second    O
electron    O
arrives    O
from    O
the    O
[    O
3Fe-4S    O
]    O
cluster    O
to    O
provide    O
full    O
reduction    O
of    O
the    O
ubiquinone    O
to    O
ubiquinol    B-Antioxidant114724645
.    O

The    O
second    O
electron    O
arrives    O
from    O
the    O
[    O
3Fe-4S    O
]    O
cluster    O
to    O
provide    O
full    O
reduction    O
of    O
the    O
ubiquinone    O
to    O
ubiquinol    B-Antioxidant114724645
.    O

Myxothiazol    O
is    O
a    O
competitive    O
inhibitor    O
of    O
ubiquinol    B-Antioxidant114724645
,    O
and    O
binds    O
at    O
the    O
quinol    O
oxidation    O
(    O
Qo    O
)    O
site    O
of    O
the    O
bc1    O
complex    O
,    O
blocking    O
electron    O
transfer    O
to    O
the    O
Rieske    O
iron    O
-    O
sulfur    O
protein    O
.    O

Tocofersolan    O
is    O
polyethylene    O
glycol    O
derivative    O
of    O
α-tocopherol    B-Antioxidant114724645
that    O
enables    O
water    O
solubility    O
.    O

Protection    O
from    O
Alzheimer    O
's    O
disease    O
by    O
apo    O
A1    O
may    O
rely    O
on    O
a    O
synergistic    O
interaction    O
with    O
alpha-tocopherol    B-Antioxidant114724645
.    O

The    O
main    O
carotenoids    O
are    O
beta    O
-    O
carotene    O
,    O
zeaxanthin    O
and    O
lycopene    O
while    O
alpha-tocopherol    B-Antioxidant114724645
is    O
the    O
major    O
vitamin    O
E    O
compound    O
.    O

For    O
example    O
,    O
α-tocopherol    B-Antioxidant114724645
is    O
present    O
in    O
higher    O
concentrations    O
in    O
the    O
secretions    O
of    O
red    O
morphs    O
.    O

Nevertheless    O
,    O
experiments    O
led    O
with    O
hydroxytyrosol    O
,    O
a    O
major    O
constituent    O
of    O
olive    O
oil    O
and    O
α-tocopherol    B-Antioxidant114724645
show    O
a    O
synergistic    O
effect    O
.    O

Synthetic    O
antioxidants    O
include    O
butylated    B-Antioxidant114724645
hydroxyanisole    I-Antioxidant114724645
(    O
BHA    O
)    O
,    O
butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
(    O
BHT    O
)    O
,    O
TBHQ    B-Antioxidant114724645
,    O
propyl    B-Antioxidant114724645
gallate    I-Antioxidant114724645
and    O
ethoxyquin    B-Antioxidant114724645
.    O

Synthetic    B-Antioxidant114724645
catalytic    I-Antioxidant114724645
scavenger    I-Antioxidant114724645

In    O
1992    O
a    O
team    O
of    O
Johns    O
Hopkins    O
University    O
scientists    O
isolated    O
a    O
cancer    O
-    O
fighting    O
phytochemical    O
in    O
broccoli    O
called    O
glucoraphanin    O
,    O
which    O
is    O
the    O
glucosinolate    O
precursor    O
of    O
sulforaphane    B-Antioxidant114724645
(    O
SGS    O
)    O
.    O

Glucoraphanin    O
is    O
the    O
precursor    O
to    O
sulforaphane    B-Antioxidant114724645

Plants    O
producing    O
large    O
amounts    O
of    O
glucosinolates    O
are    O
under    O
basic    O
research    O
for    O
potential    O
actions    O
against    O
cancer    O
,    O
with    O
the    O
hydrolysis    O
product    O
of    O
the    O
glucoraphanin    O
(    O
the    O
primary    O
glucosinolate    O
in    O
broccoli    O
)    O
,    O
sulforaphane    B-Antioxidant114724645
,    O
being    O
the    O
best    O
known    O
example    O
.    O

His    O
work    O
focuses    O
on    O
effects    O
of    O
HIV    O
and    O
drug    O
use    O
,    O
particularly    O
alcohol    O
,    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
,    O
and    O
methamphetamine    O
.    O

The    O
Sisters    O
have    O
been    O
involved    O
in    O
various    O
causes    O
,    O
including    O
the    O
promotion    O
of    O
safer    O
sex    O
,    O
raising    O
money    O
for    O
HIV    O
/    O
AIDS    O
and    O
breast    O
cancer    O
research    O
,    O
the    O
Gay    O
Games    O
,    O
Haight    O
Ashbury    O
Free    O
Clinics    O
,    O
and    O
raising    O
the    O
"    O
first    O
legal    O
$    O
1000    O
"    O
for    O
a    O
city    O
proposition    O
to    O
legalize    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
.    O

medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
activists    O
Brownie    O
Mary    O
and    O
Ed    O
Rosenthal    O

:    O
If    O
we    O
allow    O
people    O
with    O
glaucoma    O
to    O
use    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
,    O
then    O
everyone    O
should    O
be    O
allowed    O
to    O
use    O
marijuana    O
.    O

Grimes    O
has    O
also    O
been    O
publicly    O
critical    O
of    O
a    O
medicinal    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
campaign    O
by    O
People    O
Before    O
Profit    O
,    O
specifically    O
cure    O
-    O
all    O
claims    O
made    O
by    O
representatives    O
of    O
the    O
campaign    O
.    O

In    O
June    O
2014    O
,    O
Clinton    O
said    O
that    O
on    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
,    O
"    O
I    O
do    O
n't    O
think    O
we    O
've    O
done    O
enough    O
research    O
yet    O
.    O

Ned    O
even    O
meets    O
his    O
Canadian    O
counterpart    O
,    O
but    O
takes    O
an    O
instant    O
dislike    O
to    O
him    O
when    O
he    O
offers    O
Ned    O
a    O
"    O
reeferino    B-Antioxidant114724645
"    O
.    O

The    O
federalist    O
trend    O
set    O
by    O
"    O
Lopez    O
"    O
and    O
"    O
Morrison    O
"    O
was    O
seemingly    O
halted    O
by    O
"    O
Gonzales    O
v.    O
Raich    O
"    O
(    O
2005    O
)    O
,    O
in    O
which    O
the    O
court    O
broadly    O
interpreted    O
the    O
Commerce    O
Clause    O
to    O
allow    O
Congress    O
to    O
prohibit    O
the    O
intrastate    O
cultivation    O
of    O
medicinal    B-Antioxidant114724645
cannabis    O
.    O

It    O
supports    O
the    O
legalization    O
of    O
medicinal    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
,    O
and    O
more    O
liberal    O
drug    O
laws    O
in    O
general    O
.    O

Medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645

The    O
California    O
Cannabis    O
Research    O
Medical    O
Group    O
(    O
CCRMG    O
)    O
is    O
a    O
501c3    O
non    O
-    O
profit    O
organization    O
dedicated    O
to    O
educating    O
physicians    O
about    O
the    O
medical    B-Antioxidant114724645
use    I-Antioxidant114724645
of    I-Antioxidant114724645
cannabis    I-Antioxidant114724645
.    O

Bud    O
and    O
Bloom    O
dispensary    O
,    O
one    O
of    O
AP    O
Investment    O
Fund    O
's    O
holdings    O
,    O
was    O
Orange    O
County    O
’s    O
11th    O
licensed    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
dispensary    O
,    O
and    O
it    O
opened    O
in    O
November    O
2016    O
.    O

Stating    O
that    O
in    O
the    O
past    O
he    O
has    O
"    O
often    O
smoked    O
cannabis    O
"    O
,    O
Johnson    O
is    O
in    O
favour    O
of    O
legalising    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
.    O

Palin    O
does    O
not    O
support    O
full    O
legalization    O
of    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
but    O
said    O
,    O
"    O
I    O
’m    O
not    O
going    O
to    O
get    O
in    O
the    O
way    O
of    O
a    O
doctor    O
prescribing    O
something    O
that    O
he    O
or    O
she    O
believes    O
will    O
help    O
a    O
cancer    O
patient    O
.    O
"    O

California    O
's    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
program    O
was    O
established    O
when    O
state    O
voters    O
approved    O
Proposition    O
215    O
(    O
also    O
known    O
as    O
the    O
Compassionate    O
Use    O
Act    O
of    O
1996    O
)    O
on    O
the    O
November    O
5    O
,    O
1996    O
ballot    O
with    O
a    O
55%    O
majority    O
.    O

California    O
was    O
the    O
first    O
state    O
to    O
establish    O
a    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
program    O
,    O
enacted    O
by    O
Proposition    O
215    O
in    O
1996    O
and    O
Senate    O
Bill    O
420    O
in    O
2003    O
.    O

In    O
2005    O
,    O
Scalia    O
concurred    O
in    O
"    O
Gonzales    O
v.    O
Raich    O
"    O
,    O
which    O
read    O
the    O
Commerce    O
Clause    O
to    O
hold    O
that    O
Congress    O
could    O
ban    O
the    O
use    O
of    O
marijuana    O
even    O
when    O
states    O
approve    O
its    O
use    O
for    O
medicinal    B-Antioxidant114724645
purposes    I-Antioxidant114724645
.    O

Ross    O
Rebagliati    O
(    O
born    O
July    O
14    O
,    O
1971    O
)    O
is    O
a    O
Canadian    O
professional    O
snowboarder    O
,    O
Olympic    O
Gold    O
Medal    O
Winner    O
and    O
founder    O
of    O
Ross    O
'    O
Gold    O
,    O
a    O
Canadian    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
branding    O
company    O
.    O

Medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645

Proposition    O
203    O
,    O
or    O
the    O
Arizona    O
Medical    O
Marijuana    O
Act    O
,    O
was    O
an    O
Arizona    O
ballot    O
measure    O
to    O
legalize    O
the    O
use    O
of    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
without    O
the    O
normal    O
Food    O
and    O
Drug    O
Administration    O
testing    O
for    O
safety    O
and    O
efficacy    O
.    O

This    O
new    O
law    O
states    O
that    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
can    O
not    O
be    O
possessed    O
or    O
used    O
at    O
educational    O
institutions    O
.    O

Nor    O
does    O
the    O
pharmacy    O
carry    O
sildenafil    O
(    O
Viagra    O
)    O
or    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
.    O

Greene    O
received    O
media    O
notice    O
after    O
she    O
quit    O
her    O
job    O
on    O
-    O
air    O
in    O
September    O
2014    O
while    O
covering    O
a    O
story    O
on    O
the    O
Alaska    O
Cannabis    O
Club    O
,    O
a    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
organization    O
,    O
revealing    O
that    O
she    O
was    O
the    O
owner    O
of    O
the    O
business    O
.    O

Medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645

Dr.    O
Jay    O
Cavanaugh    O
(    O
1949–2005    O
)    O
was    O
a    O
prominent    O
supporter    O
of    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
.    O

According    O
to    O
her    O
biography    O
on    O
SWOP    O
's    O
website    O
,    O
she    O
had    O
worked    O
as    O
an    O
exotic    O
dancer    O
,    O
then    O
pursued    O
a    O
college    O
degree    O
in    O
theater    O
,    O
and    O
was    O
active    O
in    O
the    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
movement    O
in    O
California    O
.    O

Medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
has    O
been    O
allowed    O
for    O
the    O
treatment    O
of    O
cachexia    O
in    O
some    O
US    O
states    O
,    O
such    O
as    O
Illinois    O
,    O
Maryland    O
,    O
Delaware    O
,    O
Nevada    O
,    O
Michigan    O
,    O
Washington    O
,    O
Oregon    O
,    O
California    O
,    O
Colorado    O
,    O
New    O
Mexico    O
,    O
Arizona    O
,    O
Vermont    O
,    O
New    O
Jersey    O
,    O
Rhode    O
Island    O
,    O
Maine    O
,    O
and    O
New    O
York    O
Hawaii    O
and    O
Connecticut    O
.    O

During    O
a    O
hearing    O
on    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
,    O
52-year    O
-    O
old    O
Pinchas    O
Cohen    O
hurled    O
his    O
sneaker    O
at    O
President    O
of    O
the    O
Supreme    O
Court    O
of    O
Israel    O
Dorit    O
Beinisch    O
.    O

More    O
recent    O
amendments    O
include    O
the    O
nation    O
's    O
first    O
doctor    O
-    O
assisted    O
suicide    O
law    O
,    O
called    O
the    O
Death    O
with    O
Dignity    O
Act    O
(    O
which    O
was    O
challenged    O
,    O
unsuccessfully    O
,    O
in    O
2005    O
by    O
the    O
Bush    O
administration    O
in    O
a    O
case    O
heard    O
by    O
the    O
U.S.    O
Supreme    O
Court    O
)    O
,    O
legalization    O
of    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
,    O
and    O
among    O
the    O
nation    O
's    O
strongest    O
anti    O
-    O
urban    O
sprawl    O
and    O
pro    O
-    O
environment    O
laws    O
.    O

The    O
Michigan    O
Compassionate    O
Care    O
Initiative    O
is    O
an    O
indirect    O
initiated    O
state    O
statute    O
that    O
will    O
allow    O
the    O
medical    B-Antioxidant114724645
use    I-Antioxidant114724645
of    I-Antioxidant114724645
marijuana    I-Antioxidant114724645
for    O
seriously    O
ill    O
patients    O
.    O

Medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645

He    O
has    O
also    O
expressed    O
support    O
for    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
research    O
,    O
decriminalizing    O
marijuana    O
,    O
ending    O
mandatory    O
minimum    O
sentences    O
for    O
non    O
-    O
violent    O
drug    O
offenders    O
,    O
increasing    O
funding    O
for    O
prisoner    O
re    O
-    O
entry    O
programs    O
,    O
and    O
bringing    O
an    O
end    O
to    O
for    O
-    O
profit    O
,    O
private    O
prisons    O
.    O

Ames    O
studied    O
the    O
effects    O
of    O
cannabis    O
on    O
the    O
brain    O
and    O
published    O
several    O
articles    O
on    O
the    O
subject    O
;    O
seeing    O
the    O
therapeutic    O
benefits    O
of    O
cannabis    O
on    O
patients    O
in    O
her    O
own    O
hospital    O
,    O
she    O
became    O
an    O
early    O
proponent    O
of    O
legalization    O
for    O
medicinal    B-Antioxidant114724645
use    I-Antioxidant114724645
.    O

She    O
opposed    O
the    O
War    O
on    O
Drugs    O
and    O
was    O
a    O
proponent    O
of    O
the    O
therapeutic    B-Antioxidant114724645
benefits    I-Antioxidant114724645
of    I-Antioxidant114724645
cannabis    I-Antioxidant114724645
,    O
particularly    O
for    O
people    O
with    O
multiple    O
sclerosis    O
(    O
MS    O
)    O
.    O

Medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
-    O

Though    O
not    O
interested    O
in    O
school    O
,    O
Kumar    O
is    O
remarkably    O
intelligent    O
and    O
knows    O
how    O
to    O
perform    O
complex    O
surgical    O
procedures    O
,    O
as    O
shown    O
in    O
the    O
film    O
while    O
looking    O
for    O
medicinal    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
at    O
the    O
hospital    O
.    O

In    O
2011    O
,    O
Cedars    O
-    O
Sinai    O
again    O
created    O
controversy    O
by    O
denying    O
a    O
liver    O
transplant    O
to    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
patient    O
Norman    O
Smith    O
.    O

Aryeh    O
Eldad    O
supports    O
legalizing    O
the    O
medical    B-Antioxidant114724645
use    I-Antioxidant114724645
of    I-Antioxidant114724645
cannabis    I-Antioxidant114724645
in    O
Israel    O
,    O
and    O
has    O
sponsored    O
legislation    O
to    O
that    O
effect    O
.    O

John    O
Sperling    O
was    O
also    O
an    O
opponent    O
of    O
drug    O
prohibition    O
and    O
was    O
financing    O
initiatives    O
to    O
decriminalize    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
in    O
the    O
United    O
States    O
.    O

Other    O
subjects    O
they    O
have    O
investigated    O
as    O
part    O
of    O
such    O
projects    O
include    O
the    O
lives    O
of    O
veterans    O
in    O
the    O
U.S.    O
,    O
the    O
experience    O
one    O
family    O
in    O
Louisiana    O
had    O
after    O
the    O
Deepwater    O
Horizon    O
oil    O
spill    O
,    O
and    O
the    O
variation    O
in    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
laws    O
from    O
state    O
to    O
state    O
.    O

Marijuana    B-Antioxidant114724645
and    O
tetrahydrocannabinol    O
can    O
on    O
occasion    O
produce    O
marked    O
orthostatic    O
hypotension    O
.    O

Raskin    O
also    O
introduced    O
Senate    O
legislation    O
to    O
legalize    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
in    O
Maryland    O
in    O
2014    O
.    O

The    O
World    O
Famous    O
Cannabis    O
Cafe    O
opened    O
in    O
Portland    O
,    O
Oregon    O
,    O
as    O
the    O
first    O
cafe    O
in    O
the    O
United    O
States    O
for    O
state    O
-    O
authorized    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
cardholders    O
.    O

She    O
is    O
so    O
dedicated    O
to    O
her    O
job    O
that    O
she    O
refuses    O
to    O
use    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
because    O
,    O
at    O
the    O
time    O
,    O
it    O
is    O
illegal    O
;    O
however    O
,    O
she    O
starts    O
using    O
it    O
after    O
the    O
Chief    O
of    O
Detectives    O
,    O
a    O
testicular    O
cancer    O
survivor    O
,    O
says    O
he    O
will    O
look    O
the    O
other    O
way    O
if    O
she    O
keeps    O
it    O
discreet    O
.    O

In    O
2007    O
,    O
Mescher    O
gained    O
media    O
attention    O
when    O
he    O
proposed    O
a    O
bill    O
to    O
legalize    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
in    O
South    O
Carolina    O
.    O

John    O
Morgan    O
,    O
personal    O
injury    O
lawyer    O
and    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
advocate    O

He    O
is    O
also    O
a    O
member    O
of    O
the    O
Institute    O
of    O
Medicine    O
(    O
IOM    O
)    O
of    O
the    O
National    O
Academy    O
of    O
Sciences    O
and    O
served    O
as    O
a    O
principal    O
investigator    O
for    O
the    O
study    O
on    O
which    O
a    O
1999    O
IOM    O
report    O
on    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
was    O
based    O
.    O

The    O
Rhode    O
Island    O
Patient    O
Advocacy    O
Coalition    O
(    O
RIPAC    O
)    O
is    O
Rhode    O
Island    O
's    O
non    O
-    O
profit    O
grassroots    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
community    O
.    O

In    O
2014    O
,    O
Carson    O
said    O
that    O
"    O
I    O
think    O
medical    B-Antioxidant114724645
use    I-Antioxidant114724645
of    I-Antioxidant114724645
marijuana    I-Antioxidant114724645
in    O
compassionate    O
cases    O
certainly    O
has    O
been    O
proven    O
to    O
be    O
useful    O
"    O
but    O
said    O
that    O
he    O
opposed    O
legalization    O
of    O
recreational    O
marijuana    O
.    O

CanniMed    O
Ltd.    O
is    O
a    O
privately    O
held    O
licensed    O
producer    O
of    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
under    O
the    O
Marihuana    O
for    O
Medical    O
Purposes    O
Regulations    O
(    O
MMPR    O
)    O
governed    O
by    O
Health    O
Canada    O
.    O

In    O
1998    O
,    O
when    O
the    O
Oakland    O
City    O
Council    O
deputized    O
the    O
Oakland    O
Cannabis    O
Buyer    O
's    O
Cooperative    O
to    O
distribute    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
,    O
De    O
La    O
Fuente    O
cast    O
a    O
negative    O
vote    O
,    O
saying    O
that    O
he    O
could    O
not    O
support    O
such    O
efforts    O
in    O
"    O
good    O
conscience    O
,    O
"    O
citing    O
concerns    O
over    O
abuse    O
as    O
well    O
as    O
control    O
,    O
certification    O
,    O
and    O
monitoring    O
of    O
caregivers    O
.    O

Recognizing    O
Barr    O
's    O
precarious    O
situation    O
,    O
the    O
Libertarian    O
Party    O
seized    O
on    O
the    O
opportunity    O
to    O
oust    O
one    O
of    O
the    O
federal    O
drug    O
war    O
's    O
most    O
vocal    O
proponents    O
(    O
Barr    O
)    O
,    O
and    O
ran    O
TV    O
ads    O
criticizing    O
Barr    O
's    O
opposition    O
to    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
during    O
the    O
Republican    O
primaries    O
.    O

The    O
bill    O
,    O
"    O
would    O
let    O
doctor    O
-    O
certified    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
users    O
grow    O
plants    O
,    O
but    O
they    O
would    O
have    O
to    O
be    O
kept    O
in    O
a    O
locked    O
room    O
,    O
greenhouse    O
,    O
garden    O
,    O
closet    O
or    O
other    O
enclosed    O
area    O
out    O
of    O
view    O
.    O

In    O
the    O
2007    O
landmark    O
free    O
speech    O
case    O
"    O
Morse    O
v.    O
Frederick    O
"    O
,    O
Alito    O
joined    O
Roberts    O
'    O
majority    O
decision    O
that    O
speech    O
advocating    O
drug    O
use    O
can    O
be    O
banned    O
in    O
public    O
schools    O
,    O
but    O
also    O
warned    O
that    O
the    O
ruling    O
must    O
be    O
circumscribed    O
that    O
it    O
does    O
not    O
interfere    O
with    O
political    O
speech    O
,    O
such    O
as    O
the    O
discussion    O
of    O
the    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
debate    O
.    O

Proposition    O
215    O
,    O
or    O
the    O
Compassionate    O
Use    O
Act    O
of    O
1996    O
,    O
is    O
a    O
California    O
law    O
allowing    O
the    O
use    O
of    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
despite    O
marijuana    O
's    O
lack    O
of    O
the    O
normal    O
Food    O
and    O
Drug    O
Administration    O
testing    O
for    O
safety    O
and    O
efficacy    O
.    O

Medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645

In    O
2013    O
,    O
Marzel    O
served    O
as    O
the    O
defence    O
lawyer    O
for    O
Maxim    O
Popovitch    O
,    O
a    O
medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
seller    O
and    O
grower    O
.    O

Ann    O
Arbor    O
has    O
a    O
long    O
history    O
of    O
openness    O
to    O
marijuana    O
,    O
given    O
Ann    O
Arbor    O
's    O
decriminalization    O
of    O
cannabis    O
,    O
the    O
large    O
number    O
of    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
dispensaries    O
in    O
the    O
city    O
(    O
one    O
dispensary    O
,    O
called    O
People    O
's    O
Co    O
-    O
op    O
,    O
was    O
directly    O
across    O
the    O
street    O
from    O
Michigan    O
Stadium    O
until    O
zoning    O
forced    O
it    O
to    O
move    O
one    O
mile    O
to    O
the    O
west    O
)    O
,    O
the    O
large    O
number    O
of    O
pro    O
-    O
marijuana    O
residents    O
,    O
and    O
the    O
annual    O
Hash    O
Bash    O
:    O
an    O
event    O
that    O
is    O
held    O
on    O
the    O
first    O
Saturday    O
of    O
April    O
.    O

Kush    O
strains    O
were    O
among    O
those    O
cultivated    O
by    O
the    O
British    O
firm    O
GW    O
Pharmaceuticals    O
for    O
its    O
legally    O
licensed    O
commercial    O
trial    O
of    O
medicinal    B-Antioxidant114724645
cannabis    I-Antioxidant114724645
.    O

Medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645

This    O
episode    O
focused    O
on    O
a    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
patient    O
who    O
was    O
denied    O
a    O
job    O
for    O
failing    O
a    O
drug    O
test    O
.    O

Polis    O
also    O
advocated    O
the    O
legalization    O
of    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
to    O
combat    O
prescription    O
drug    O
abuse    O
.    O

Medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645

Medical    B-Antioxidant114724645
cannabis    I-Antioxidant114724645

On    O
November    O
30    O
,    O
2010    O
,    O
while    O
the    O
politician    O
was    O
still    O
being    O
subjected    O
to    O
monthly    O
drug    O
tests    O
,    O
Ron    O
Stephens    O
was    O
one    O
of    O
the    O
biggest    O
opponents    O
of    O
and    O
voted    O
against    O
the    O
proposed    O
medical    B-Antioxidant114724645
marijuana    I-Antioxidant114724645
bill    O
in    O
Illinois    O
.    O

Flowers    O
,    O
fruits    O
,    O
and    O
leaves    O
get    O
their    O
pigments    O
from    O
anthocyanins    O
and    O
copigments    O
(    O
such    O
as    O
tannings    O
and    O
flavonols    B-Antioxidant114724645
)    O
.    O

Along    O
this    O
pathway    O
,    O
many    O
products    O
can    O
be    O
formed    O
,    O
including    O
the    O
flavonol    B-Antioxidant114724645
,    O
flavan-3-ol    B-Antioxidant114724645
,    O
proanthocyanidins    O
(    O
tannins    O
)    O
and    O
a    O
host    O
of    O
other    O
various    O
polyphenolics    O
.    O

Kaempferol    O
is    O
a    O
natural    O
flavonol    B-Antioxidant114724645
,    O
a    O
type    O
of    O
flavonoid    O
,    O
found    O
in    O
a    O
variety    O
of    O
plants    O
and    O
plant    O
-    O
derived    O
foods    O
.    O

An    O
eight    O
-    O
year    O
study    O
found    O
the    O
consumption    O
of    O
three    O
flavonol    B-Antioxidant114724645
(    O
kaempferol    O
,    O
quercetin    O
,    O
and    O
myricetin    O
)    O
correlated    O
with    O
a    O
lower    O
risk    O
of    O
pancreatic    O
cancer    O
among    O
current    O
smokers    O
,    O
but    O
not    O
non    O
-    O
smokers    O
or    O
ex    O
-    O
smokers    O
.    O

Flavonols    B-Antioxidant114724645
–    O

Apple    O
juice    O
has    O
a    O
significant    O
concentration    O
of    O
natural    O
phenols    O
of    O
low    O
molecular    O
weight    O
(    O
including    O
chlorogenic    O
acid    O
,    O
flavan-3-ol    B-Antioxidant114724645
,    O
and    O
flavonol    B-Antioxidant114724645
)    O
and    O
procyanidin    B-Antioxidant114724645
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
malonyl    O
-    O
CoA    O
and    O
flavonol    B-Antioxidant114724645
3-O-beta-D-glucoside    I-Antioxidant114724645
,    O
whereas    O
its    O
two    O
products    O
are    O
CoA    O
and    O
flavonol    B-Antioxidant114724645
3-O-(6-O-malonyl-beta-D-glucoside)    I-Antioxidant114724645
.    O

The    O
3    O
substrates    O
of    O
this    O
enzyme    O
are    O
4-coumaroyl    O
-    O
CoA    O
,    O
flavonol    B-Antioxidant114724645
,    O
and    O
3-O    O
-    O
beta    O
-    O
D    O
-    O
glucosyl-(1->2)-beta    O
-    O
D    O
-    O
glucosyl-(1->2)-beta    O
-    O
D    O
-    O
glucoside    O
,    O
whereas    O
its    O
4    O
products    O
are    O
CoA    O
,    O
flavonol    B-Antioxidant114724645
,    O
[    O
[    O
3-O-[6-(4-coumaroyl)-beta    O
-    O
D    O
-    O
glucosyl-(1->2)-beta    O
-    O
D    O
-    O
glucosyl-(1->2)-    O
]    O
]    O
,    O
and    O
beta    O
-    O
D    O
-    O
glucoside    O
]    O
.    O

Avicularin    O
is    O
a    O
bio    O
-    O
active    O
flavonol    B-Antioxidant114724645
isolated    O
from    O
a    O
number    O
of    O
plants    O
including    O
"    O
Polygonum    O
aviculare    O
"    O
,    O
"    O
Rhododendron    O
aureum    O
"    O
and    O
"    O
Taxillus    O
kaempferi    O
"    O
.    O

Flavonol    B-Antioxidant114724645
were    O
found    O
to    O
be    O
the    O
predominating    O
class    O
of    O
phenolic    O
compounds    O
while    O
phenolic    O
acids    O
and    O
flavan-3-ol    B-Antioxidant114724645
(    O
"    O
catechins    O
"    O
)    O
represent    O
minor    O
components    O
.    O

Eupalitin    O
3-O-β-D    O
-    O
galactopyranoside    O
,    O
a    O
glycoside    O
of    O
the    O
flavonol    B-Antioxidant114724645
eupalitin    O
,    O
can    O
be    O
isolated    O
from    O
"    O
T.    O
spinosa    O
"    O
.    O

Desmethoxycurcumin    B-Antioxidant114724645
is    O
a    O
curcuminoid    O
found    O
in    O
turmeric    O
.    O

Synthetic    O
antioxidants    O
include    O
butylated    B-Antioxidant114724645
hydroxyanisole    I-Antioxidant114724645
(    O
BHA    O
)    O
,    O
butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
(    O
BHT    O
)    O
,    O
TBHQ    B-Antioxidant114724645
,    O
propyl    B-Antioxidant114724645
gallate    I-Antioxidant114724645
and    O
ethoxyquin    B-Antioxidant114724645
.    O

The    O
same    O
ratio    O
of    O
gallic    B-Antioxidant114724645
acid    I-Antioxidant114724645
n-propyl    I-Antioxidant114724645
ester    I-Antioxidant114724645
in    O
sulfuric    O
acid    O
can    O
also    O
be    O
used    O
.    O

Epigallocatechin    B-Antioxidant114724645
gallate    I-Antioxidant114724645
(    O
EGCG    O
)    O
,    O
a    O
catechin    O
in    O
green    O
tea    O
,    O
binds    O
to    O
gp120    O
,    O
which    O
works    O
in    O
conjunction    O
with    O
gp41    O
,    O
itself    O
blocked    O
by    O
TF-3    B-Antioxidant114724645
(    O
a    O
theaflavin    O
)    O
,    O
both    O
receptors    O
of    O
which    O
HIV    O
hijacks    O
to    O
enter    O
into    O
healthy    O
human    O
immune    O
cells    O
.    O

Some    O
of    O
the    O
mild    O
stresses    O
used    O
for    O
such    O
studies    O
on    O
the    O
application    O
of    O
hormesis    O
in    O
aging    O
research    O
and    O
interventions    O
are    O
heat    O
shock    O
,    O
irradiation    O
,    O
prooxidants    B-Antioxidant114724645
,    O
hypergravity    O
and    O
food    O
restriction    O
.    O

Pharmacological    O
experiments    O
suggest    O
that    O
DCPIP    O
may    O
serve    O
as    O
a    O
pro-oxidant    B-Antioxidant114724645
chemotherapeutic    O
targeting    O
human    O
cancer    O
cells    O
in    O
an    O
animal    O
model    O
of    O
human    O
melanoma    O
;    O
DCPIP    O
-    O
induced    O
cancer    O
cell    O
death    O
occurs    O
by    O
depletion    O
of    O
intracellular    O
glutathione    B-Antioxidant114724645
and    O
upregulation    O
of    O
oxidative    O
stress    O
.    O

Pro-oxidant    B-Antioxidant114724645

In    O
May    O
2014    O
Retrophin    O
acquired    O
the    O
rights    O
to    O
market    O
Thiola    B-Antioxidant114724645
,    O
a    O
drug    O
used    O
to    O
treat    O
the    O
rare    O
disease    O
cystinuria    O
.    O

Tiopronin    B-Antioxidant114724645
–    O
trade    O
name    O
Thiola    O
,    O
a    O
drug    O
controlled    O
by    O
Shkreli    O
's    O
company    O
Retrophin    O
(    O
which    O
experienced    O
a    O
price    O
increase    O
similar    O
to    O
Daraprim    O
's    O
)    O

Vinyldithiin    B-Antioxidant114724645
,    O
a    O
common    O
component    O
of    O
garlic    O
,    O
is    O
a    O
misnomer    O
for    O
3-vinyl-4"H"-1,2-dithiin    O
,    O
since    O
true    O
1,3-dithiins    O
are    O
unknown    O
.    O

Isorenieratene    B-Antioxidant114724645
,    O
a    O
pigment    O
known    O
as    O
a    O
proxy    O
for    O
an    O
anoxic    O
photic    O
zone    O
,    O
has    O
been    O
found    O
in    O
the    O
geological    O
record    O
in    O
Illinois    O
and    O
Michigan    O
.    O

Pterostilbene    B-Antioxidant114724645
-    O
methoxylated    O
analogue    O
of    O
resveratrol    O
,    O
abundant    O
in    O
"    O
Vaccinium    O
"    O
berries    O

MitoQ    B-Antioxidant114724645
,    O
resveratrol    O
and    O
pterostilbene    B-Antioxidant114724645
are    O
dietary    O
supplements    O
that    O
have    O
also    O
been    O
studied    O
in    O
this    O
context    O
.    O

The    O
developer    O
of    O
oxygen    O
diffusion    O
-    O
enhancing    O
compounds    O
,    O
Diffusion    O
Pharmaceuticals    O
,    O
tested    O
its    O
lead    O
compound    O
,    O
trans    B-Antioxidant114724645
sodium    I-Antioxidant114724645
crocetinate    I-Antioxidant114724645
(    O
TSC    O
)    O
,    O
in    O
a    O
Phase    O
II    O
clinical    O
trial    O
in    O
59    O
patients    O
newly    O
diagnosed    O
with    O
glioblastoma    O
multiforme    O
.    O

Gainer    O
is    O
the    O
inventor    O
of    O
the    O
company    O
’s    O
platform    O
technology    O
of    O
oxygen    O
diffusion    O
-    O
enhancing    O
compounds    O
and    O
its    O
lead    O
drug    O
,    O
trans    B-Antioxidant114724645
sodium    I-Antioxidant114724645
crocetinate    I-Antioxidant114724645
(    O
TSC    O
)    O
.    O

At    O
that    O
time    O
,    O
crocetin    B-Antioxidant114724645
,    O
a    O
naturally    O
occurring    O
carotenoid    O
compound    O
,    O
was    O
the    O
focus    O
of    O
their    O
research    O
.    O

Canthaxanthin    B-Antioxidant114724645

Finally    O
,    O
"    O
Lamprologus    O
ocellatus    O
"    O
are    O
similar    O
to    O
other    O
African    O
Cichlids    O
in    O
that    O
their    O
coloring    O
will    O
benefit    O
from    O
a    O
diet    O
containing    O
quantities    O
of    O
beta    O
-    O
carotene    O
and    O
canthaxanthin    B-Antioxidant114724645
.    O

Two    O
red    O
keto    O
-    O
carotenoid    O
pigments    O
,    O
canthaxanthin    B-Antioxidant114724645
and    O
adonirubin    O
,    O
are    O
responsible    O
for    O
the    O
redness    O
in    O
the    O
red    O
-    O
capped    O
robin    O
's    O
plumage    O
.    O

Three    O
classes    O
of    O
enediynes    O
have    O
since    O
been    O
identified    O
:    O
calicheamicin    O
,    O
dynemicin    O
,    O
and    O
chromoprotein    B-Antioxidant114724645
based    O
products    O
.    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
as    O
retinyl    B-Antioxidant114724645
palmitate    I-Antioxidant114724645

Reduced    O
-    O
fat    O
milks    O
often    O
have    O
added    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
palmitate    I-Antioxidant114724645
to    O
compensate    O
for    O
the    O
loss    O
of    O
the    O
vitamin    O
during    O
fat    O
removal    O
;    O
in    O
the    O
United    O
States    O
this    O
results    O
in    O
reduced    O
fat    O
milks    O
having    O
a    O
higher    O
vitamin    O
A    O
content    O
than    O
whole    O
milk    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
retinyl    B-Antioxidant114724645
palmitate    I-Antioxidant114724645
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
retinol    O
and    O
palmitate    O
.    O

Neurosporene    B-Antioxidant114724645

The    O
next    O
series    O
of    O
desaturation    O
reactions    O
is    O
catalyzed    O
by    O
the    O
enzyme    O
ζ-carotene    O
desaturase    O
(    O
ZDS    O
)    O
to    O
produced    O
neurosporene    B-Antioxidant114724645
followed    O
by    O
lycopene    O
.    O

Grapefruit    B-Antioxidant114724645
seed    I-Antioxidant114724645
extract    I-Antioxidant114724645
(    O
GSE    O
)    O
,    O
also    O
known    O
as    O
citrus    B-Antioxidant114724645
seed    I-Antioxidant114724645
extract    I-Antioxidant114724645
,    O
is    O
a    O
liquid    O
extract    O
derived    O
from    O
the    O
seeds    O
,    O
pulp    O
,    O
and    O
white    O
membranes    O
of    O
grapefruit    O
.    O

Analysis    O
of    O
several    O
fruits    O
and    O
vegetables    O
showed    O
that    O
phytoene    O
and    O
phytofluene    B-Antioxidant114724645
are    O
found    O
in    O
majority    O
of    O
fruits    O
and    O
vegetables    O
.    O

Sesame    O
seeds    O
contain    O
the    O
lignans    O
sesamolin    B-Antioxidant114724645
,    O
sesamin    B-Antioxidant114724645
,    O
pinoresinol    O
and    O
lariciresinol    O
.    O

Many    O
multivitamin    O
"    O
formulas    O
"    O
contain    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
B1    O
,    O
B2    O
,    O
B3    O
,    O
B5    O
,    O
B6    O
,    O
B9    O
,    O
B12    O
,    O
biotin    O
,    O
A    B-Antioxidant114724645
,    O
E    O
,    O
D2    O
(    O
or    O
D3    O
)    O
,    O
K    O
,    O
potassium    O
,    O
iodine    O
,    O
selenium    O
,    O
borate    O
,    O
zinc    O
,    O
calcium    O
,    O
magnesium    O
,    O
manganese    O
,    O
molybdenum    O
,    O
betacarotene    O
,    O
and/or    O
iron    O
.    O

In    O
particular    O
,    O
pregnant    O
women    O
should    O
generally    O
consult    O
their    O
doctors    O
before    O
taking    O
any    O
multivitamins    O
:    O
for    O
example    O
,    O
either    O
an    O
excess    O
or    O
deficiency    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
can    O
cause    O
birth    O
defects    O
.    O

Long    O
-    O
term    O
use    O
of    O
beta    O
-    O
carotene    O
,    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
and    O
vitamin    O
E    O
supplements    O
may    O
shorten    O
life    O
,    O
and    O
increase    O
the    O
risk    O
of    O
lung    O
cancer    O
in    O
people    O
who    O
smoke    O
(    O
especially    O
those    O
smoking    O
more    O
than    O
20    O
cigarettes    O
per    O
day    O
)    O
,    O
former    O
smokers    O
,    O
people    O
exposed    O
to    O
asbestos    O
,    O
and    O
those    O
who    O
use    O
alcohol    O
.    O

Black    O
-    O
eyed    O
peas    O
contain    O
calcium    O
(    O
41    O
mg    O
)    O
folate    O
(    O
356    O
mcg    O
)    O
,    O
protein    O
(    O
13.22    O
g    O
)    O
,    O
fiber    O
(    O
11.1    O
g    O
)    O
and    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
(    O
26    O
IU    O
)    O
,    O
among    O
other    O
nutrients    O
,    O
all    O
for    O
less    O
than    O
200    O
Calories    O
,    O
in    O
a    O
171-g    O
,    O
one    O
-    O
cup    O
serving    O
.    O

Rothman    O
is    O
known    O
for    O
his    O
work    O
on    O
,    O
and    O
teaching    O
about    O
,    O
epidemiologic    O
research    O
methodology    O
,    O
as    O
well    O
as    O
multiple    O
specific    O
epidemiologic    O
subjects    O
,    O
including    O
the    O
teratogenic    O
effects    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
the    O
health    O
effects    O
of    O
mobile    O
phone    O
use    O
,    O
and    O
possible    O
environmental    O
causes    O
of    O
cancer    O
.    O

A    B-Antioxidant114724645
,    O
D3    O
,    O
E    O
,    O
B6    O
,    O
B12    O
,    O
folic    O
acid    O
(    O
B9    O
)    O
,    O
ascorbic    B-Antioxidant114724645
acid    I-Antioxidant114724645
(    O
vitamin    O
C    O
)    O
,    O
along    O
with    O
a    O
vitamin    O
K    O
derivative    O
,    O
menadione    O
sodium    O
bisulfite    O
DVL    O
adds    O
these    O
vitamins    O
to    O
an    O
electrolyte    O
premix    O
that    O
has    O
7    O
mineral    O
salts    O
:    O
magnesium    O
acetate    O
,    O
sodium    O
acetate    O
,    O
calcium    O
acetate    O
,    O
potassium    O
chloride    O
,    O
calcium    O
chloride    O
,    O
sodium    O
chloride    O
and    O
sodium    O
diacetate    O
.    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
with    O
conjunctival    O
xerosis    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
with    O
Bitot    O
's    O
spot    O
and    O
conjunctival    O
xerosis    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
with    O
corneal    O
xerosis    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
with    O
corneal    O
ulceration    O
and    O
xerosis    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
with    O
keratomalacia    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
with    O
night    O
blindness    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
with    O
xerophthalmic    O
scars    O
of    O
cornea    O

Other    O
ocular    O
manifestations    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O

The    O
fat    O
-    O
soluble    O
vitamins    O
A    B-Antioxidant114724645
,    O
D    O
,    O
E    O
,    O
and    O
K    O
along    O
with    O
essential    O
fatty    O
acids    O
such    O
as    O
linoleic    O
and    O
linolenic    O
acid    O
are    O
found    O
within    O
the    O
milk    O
fat    O
portion    O
of    O
the    O
milk    O
.    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
derivatives    O
-    O
etretinate    O
,    O
isotretinoin    O

He    O
then    O
studied    O
the    O
relationship    O
between    O
protein    O
and    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
which    O
led    O
to    O
the    O
finding    O
that    O
the    O
amount    O
,    O
as    O
well    O
as    O
biological    O
value    O
,    O
of    O
dietary    O
protein    O
are    O
important    O
in    O
the    O
process    O
of    O
converting    O
carotene    O
to    O
vitamin    O
A.    O

Retinoic    O
acid    O
generated    O
from    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
in    O
the    O
retina    O
plays    O
an    O
essential    O
role    O
in    O
eye    O
development    O
as    O
a    O
secreted    O
paracrine    O
signal    O
which    O
restricts    O
invasion    O
of    O
perioptic    O
mesenchyme    O
around    O
the    O
optic    O
cup    O
.    O

Indomie    O
is    O
made    O
from    O
flour    O
supplied    O
by    O
Bogasari    O
flour    O
mills    O
,    O
and    O
fortified    O
with    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
B1    O
,    O
B6    O
,    O
B12    O
,    O
niacin    O
,    O
folic    O
acid    O
and    O
iron    O
.    O

These    O
studies    O
included    O
beriberi    O
,    O
hypoproteinemia    O
,    O
and    O
Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiencies    O
.    O

Robert    O
Turgot    O
Brinsmade    O
's    O
maternal    O
uncle    O
,    O
Harry    O
Steenbock    O
,    O
PhD    O
(    O
1886–1967    O
)    O
,    O
was    O
a    O
biochemistry    O
professor    O
at    O
the    O
University    O
of    O
Wisconsin    O
,    O
inventor    O
,    O
and    O
one    O
of    O
the    O
discoverers    O
of    O
vitamins    O
D    O
,    O
A    B-Antioxidant114724645
and    O
B.    O

Alkynylation    O
is    O
used    O
to    O
prepare    O
commodity    O
chemicals    O
such    O
as    O
propargyl    O
alcohol    O
,    O
butynediol    O
,    O
2-methyl-3-butyn-2-ol    O
(    O
a    O
precursor    O
to    O
isoprenes    O
such    O
as    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
)    O
,    O
3-hexyne-2,5-diol    O
(    O
a    O
precursor    O
to    O
Furaneol    O
)    O
,    O
and    O
2-methyl-2-hepten-6-one    O
(    O
a    O
precursor    O
to    O
Linalool    O
)    O
.    O

Leaves    O
are    O
particularly    O
rich    O
in    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
vitamin    O
K    O
,    O
with    O
moderate    O
content    O
of    O
dietary    O
minerals    O
.    O

The    O
liver    O
of    O
the    O
polar    O
bear    O
is    O
unsafe    O
to    O
eat    O
because    O
it    O
is    O
very    O
high    O
in    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
and    O
can    O
cause    O
hypervitaminosis    O
A    O
,    O
a    O
dangerous    O
disorder    O
.    O

The    O
oil    O
,    O
rich    O
in    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
is    O
produced    O
by    O
a    O
large    O
gland    O
in    O
the    O
stomach    O
.    O

The    O
Pharmanex    O
LifePak    O
Anti    O
-    O
Aging    O
supplement    O
was    O
tested    O
by    O
ConsumerLab.com    O
,    O
and    O
was    O
reported    O
as    O
failing    O
the    O
overall    O
review    O
due    O
to    O
failing    O
to    O
clearly    O
indicate    O
its    O
total    O
Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
content    O
per    O
FDA    O
requirements    O
.    O

The    O
leaves    O
contain    O
protein    O
,    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
and    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
and    O
its    O
analogues    O
.    O

=    O
=    O
Central    B-Antioxidant114724645
and    I-Antioxidant114724645
South-Eastern    I-Antioxidant114724645
Anatolian    I-Antioxidant114724645
region    O
=    O
=    O

The    O
liver    O
and    O
liver    O
products    O
(    O
such    O
as    O
cod    O
liver    O
oil    O
)    O
of    O
fish    O
and    O
many    O
animals    O
(    O
such    O
as    O
seals    O
and    O
whales    O
)    O
contain    O
omega-3    O
,    O
but    O
also    O
the    O
active    O
form    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
At    O
high    O
levels    O
,    O
this    O
form    O
of    O
the    O
vitamin    O
can    O
be    O
dangerous    O
(    O
Hypervitaminosis    O
A    O
)    O
.    O

It    O
is    O
also    O
used    O
as    O
a    O
raw    O
material    O
by    O
the    O
chemical    O
industry    O
for    O
the    O
synthesis    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
and    O
violet    O
-    O
like    O
fragrances    O
.    O

The    O
perisinusoidal    O
space    O
also    O
contains    O
hepatic    O
stellate    O
cells    O
(    O
also    O
known    O
as    O
cells    O
of    O
Ito    O
)    O
,    O
which    O
store    O
fat    O
or    O
fat    O
soluble    O
vitamins    O
including    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
)    O
.    O

Methotrexate    O
and    O
ciclosporin    O
are    O
drugs    O
that    O
suppress    O
the    O
immune    O
system    O
;    O
retinoids    O
are    O
synthetic    O
forms    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
These    O
agents    O
are    O
also    O
regarded    O
as    O
first    O
-    O
line    O
treatments    O
for    O
psoriatic    O
erythroderma    O
.    O

|    O
Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645

Vitamins    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
C    B-Antioxidant114724645
and    O
E    O
have    O
been    O
shown    O
to    O
be    O
'    O
free    O
radical    O
scavengers    O
'    O
by    O
studies    O
looking    O
for    O
protective    O
tendencies    O
of    O
antioxidants    O
.    O

There    O
is    O
some    O
evidence    O
that    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
supplementation    O
in    O
children    O
reduces    O
mortality    O
and    O
improves    O
growth    O
.    O

Retinoic    O
acid    O
is    O
a    O
metabolite    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
(    O
retinol    O
)    O
that    O
mediates    O
the    O
functions    O
of    O
vitamin    O
A    O
required    O
for    O
growth    O
and    O
development    O
.    O

Usually    O
all    O
15    O
nutrients    O
are    O
shown    O
:    O
calories    O
,    O
calories    O
from    O
fat    O
,    O
fat    O
,    O
saturated    O
fat    O
,    O
trans    O
fat    O
,    O
cholesterol    O
,    O
sodium    O
,    O
carbohydrates    O
,    O
dietary    O
fiber    O
,    O
sugars    O
,    O
protein    O
,    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
calcium    O
,    O
and    O
iron    O
.    O

Insects    O
such    O
as    O
crickets    O
and    O
meal    O
worms    O
have    O
high    O
concentrations    O
of    O
amino    O
acids    O
,    O
vitamin    O
B12    O
,    O
riboflavin    O
and    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
Insect    O
farming    O
is    O
cheaper    O
than    O
other    O
livestock    O
farming    O
and    O
requires    O
much    O
less    O
energy    O
and    O
space    O
.    O

Golden    O
rice    O
with    O
higher    O
concentrations    O
of    O
Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
was    O
originally    O
created    O
by    O
Ingo    O
Potrykus    O
and    O
his    O
team    O
.    O

an    O
excellent    O
source    O
of    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
(    O
50%    O
)    O
or    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
(    O
25%    O
)    O
or    O
folate    O
(    O
25%    O
)    O
or    O
source    O
of    O
fibre    O
(    O
2    O
grams    O
)    O

Like    O
other    O
carotenoids    O
,    O
apocarotenal    O
plays    O
a    O
role    O
as    O
a    O
precursor    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
even    O
though    O
it    O
has    O
50%    O
less    O
pro    O
-    O
vitamin    O
A    O
activity    O
than    O
β-carotene    O
.    O

Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
is    O
a    O
terpenoid    O
.    O

Insectivores    O
which    O
fed    O
on    O
unsupplemented    O
invertebrates    O
have    O
been    O
found    O
to    O
suffer    O
from    O
vitamin    O
A    O
deficiencies    O
,    O
and    O
a    O
study    O
of    O
panther    O
chameleons    O
(    O
"    O
Furcifer    O
pardalis    O
"    O
)    O
found    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
deficiency    O
shortened    O
life    O
spans    O
and    O
reduced    O
reproduction    O
rates    O
.    O

Prof    O
Harold    O
Henbest    O
,    O
Professor    O
of    O
Organic    O
Chemistry    O
from    O
1958    O
-    O
73    O
at    O
Queen    O
's    O
University    O
Belfast    O
,    O
who    O
discovered    O
the    O
link    O
between    O
retinol    O
and    O
Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
and    O
worked    O
with    O
Sir    O
Ewart    O
Jones    O
to    O
synthesize    O
cortisone    O

Cod    O
's    O
soft    O
liver    O
can    O
be    O
canned    O
or    O
fermented    O
into    O
cod    O
liver    O
oil    O
,    O
providing    O
an    O
excellent    O
source    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    O
D    O
,    O
vitamin    O
E    O
and    O
omega-3    O
fatty    O
acids    O
(    O
EPA    O
and    O
DHA    O
)    O
.    O

Their    O
line    O
of    O
Vivant    O
Skin    O
Care    O
products    O
,    O
which    O
are    O
manufactured    O
at    O
a    O
facility    O
in    O
Miami    O
Lakes    O
,    O
Florida    O
,    O
uses    O
Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
therapies    O
which    O
were    O
patented    O
by    O
Fulton    O
.    O

His    O
son    O
Thomas    O
Burr    O
Osborne    O
(    O
August    O
5    O
,    O
1859    O
–    O
January    O
29    O
,    O
1929    O
)    O
was    O
a    O
biochemist    O
and    O
co    O
-    O
discoverer    O
of    O
Vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645

While    O
working    O
at    O
the    O
Department    O
of    O
Physiology    O
in    O
Mainz    O
,    O
he    O
received    O
his    O
habilitation    O
for    O
a    O
work    O
about    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
and    O
the    O
inner    O
ear    O
.    O

Biesalski    O
worked    O
on    O
the    O
importance    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
for    O
the    O
development    O
and    O
function    O
of    O
the    O
inner    O
ear    O
and    O
for    O
lung    O
function    O
(    O
maturing    O
and    O
mucous    O
barrier    O
)    O
.    O

Night    O
blindness    O
may    O
be    O
a    O
feature    O
of    O
severe    O
zinc    O
deficiency    O
,    O
however    O
most    O
reports    O
of    O
night    O
blindness    O
and    O
abnormal    O
dark    O
adaptation    O
in    O
humans    O
with    O
zinc    O
deficiency    O
have    O
occurred    O
in    O
combination    O
with    O
other    O
nutritional    O
deficiencies    O
(    O
e.g.    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
)    O
.    O

Cooked    O
amaranth    O
leaves    O
are    O
an    O
excellent    O
source    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
,    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
calcium    O
,    O
manganese    O
,    O
and    O
folate    O
.    O

Pablum    O
Mixed    O
Cereal    O
was    O
made    O
from    O
a    O
mixture    O
of    O
ground    O
and    O
precooked    O
wheat    O
(    O
farina    O
)    O
,    O
oatmeal    O
,    O
yellow    O
corn    O
meal    O
,    O
bone    O
meal    O
,    O
dried    O
brewer    O
's    O
yeast    O
,    O
and    O
powdered    O
alfalfa    O
leaf    O
,    O
fortified    O
with    O
reduced    O
iron    O
–    O
providing    O
an    O
assortment    O
of    O
minerals    O
and    O
vitamins    O
A    B-Antioxidant114724645
,    O
B1    O
,    O
B2    O
,    O
D    O
,    O
and    O
E.    O
Pablum    O
is    O
palatable    O
and    O
easily    O
digested    O
without    O
causing    O
side    O
effects    O
like    O
diarrhea    O
or    O
constipation    O
.    O

The    O
late    O
1930s    O
saw    O
the    O
rapid    O
development    O
of    O
the    O
shark    O
fishery    O
that    O
supplied    O
shark    O
liver    O
oil    O
to    O
the    O
U.S.    O
for    O
use    O
in    O
the    O
production    O
of    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
supplements    O
(    O
Doode    O
1999    O
,    O
Bahre    O
&    O
Bourillon    O
2002    O
)    O
.    O

Nutrition    O
,    O
including    O
micronutrients    O
such    O
as    O
vitamin    B-Antioxidant114724645
A    I-Antioxidant114724645
supplementation    O
,    O
and    O
breast    O
-    O
feeding    O
.    O

Tatakin    O
(    O
4-methoxyisoscutellargin    O
)    O
,    O
takakin    O
8-O    O
-    O
glucoside    O
,    O
takakin    O
7-O    O
-    O
glucoside    O
,    O
sesamin    B-Antioxidant114724645
,    O
chrysophanol    O
,    O
emodin    O
,    O
parietin    O
,    O
bucegin    O
7-O    O
-    O
glucoside    O
,    O
isoscutellarein    O
,    O
isoscutellarein    O
7-O    O
-    O
glucoside    O
,    O
methoxsalen    O
,    O
aesculetin    O
,    O
estrone    O
,    O
scopoletin    O
,    O
phytosterols    O
(    O
a    O
mixture    O
of    O
β-sitosterol    O
,    O
stigmasterol    O
and    O
campesterol    O
)    O
and    O
α-amyrin    O
were    O
extracted    O
from    O
"    O
G.    O
bruguieri    O
"    O
.    O

The    O
soup    O
offers    O
useful    O
quantities    O
of    O
Iron    O
,    O
magnesium    O
,    O
manganese    O
,    O
copper    O
,    O
calcium    O
,    O
vitamin    O
B1    O
,    O
vitamin    O
E    O
,    O
phytic    O
acid    O
,    O
phytosterols    O
and    O
sesamin    B-Antioxidant114724645
.    O

Antioxidant    O
compounds    O
:    O
"    O
Sargassum    O
muticum    O
"    O
is    O
rich    O
in    O
antioxidant    O
compounds    O
such    O
as    O
phenolic    O
compounds    O
(    O
cathechins    B-Antioxidant114724645
,    O
phlorotannins    O
,    O
quercetins    O
)    O
,    O
pigments    O
(    O
fucoxanthin    B-Antioxidant114724645
)    O
and    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
,    O
K    O
,    O
E    O
in    O
the    O
forme    O
of    O
alpha-tocophérol    B-Antioxidant114724645
and    O
gamma-tocopherol    B-Antioxidant114724645
)    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S    O
-    O
adenosyl    O
methionine    O
and    O
gamma-tocopherol    B-Antioxidant114724645
,    O
whereas    O
its    O
two    O
products    O
are    O
S    O
-    O
adenosylhomocysteine    O
and    O
alpha-tocopherol    B-Antioxidant114724645
.    O

dodecyl    B-Antioxidant114724645
gallate    I-Antioxidant114724645
,    O
an    O
antioxidant    O

Naringin    B-Antioxidant114724645
dihydrochalcone    I-Antioxidant114724645
,    O
an    O
artificial    O
sweetener    O
derived    O
from    O
naringin    O

:    O
(    O
2    O
)    O
antheraxanthin    B-Antioxidant114724645
capsanthin    B-Antioxidant114724645

Reactive    O
astrocytes    O
defend    O
against    O
oxidative    O
stress    O
through    O
glutathione    B-Antioxidant114724645
production    O
and    O
have    O
the    O
responsibility    O
of    O
protecting    O
CNS    O
cells    O
from    O
NH4    O
+    O
toxicity    O
.    O

In    O
her    O
research    O
for    O
it    O
she    O
discovered    O
that    O
cadmium    O
binds    O
within    O
the    O
red    O
blood    O
cell    O
mostly    O
to    O
glutathione    B-Antioxidant114724645
and    O
to    O
a    O
lesser    O
degree    O
to    O
hemoglobin    O
.    O

Anaemia    O
due    O
to    O
other    O
disorders    O
of    O
glutathione    B-Antioxidant114724645
metabolism    O

He    O
studied    O
the    O
oxidation    O
of    O
glutathione    B-Antioxidant114724645
and    O
other    O
thiols    O
by    O
molecular    O
oxygen    O
and    O
measured    O
the    O
redox    O
potential    O
of    O
the    O
thiol    O
-    O
disulfide    O
system    O
,    O
also    O
establishing    O
that    O
the    O
oxidation    O
of    O
glutathione    O
was    O
catalyzed    O
by    O
trace    O
metals    O
.    O

In    O
enzymology    O
,    O
a    O
lactoylglutathione    O
lyase    O
(    O
also    O
known    O
as    O
glyoxalase    O
I    O
)    O
is    O
an    O
enzyme    O
that    O
catalyzes    O
the    O
isomerization    O
of    O
hemithioacetal    O
adducts    O
,    O
which    O
are    O
formed    O
in    O
a    O
spontaneous    O
reaction    O
between    O
a    O
glutathionyl    B-Antioxidant114724645
group    I-Antioxidant114724645
and    O
aldehydes    O
such    O
as    O
methylglyoxal    O
.    O

The    O
methylglyoxal    O
reacts    O
spontaneously    O
with    O
reduced    O
glutathione    B-Antioxidant114724645
(    O
or    O
its    O
equivalent    O
,    O
trypanothione    O
)    O
,    O
)    O
forming    O
a    O
hemithioacetal    O
.    O

The    O
former    O
enzyme    O
,    O
described    O
here    O
,    O
rearranges    O
the    O
hemithioacetal    O
formed    O
naturally    O
by    O
the    O
attack    O
of    O
glutathione    B-Antioxidant114724645
on    O
methylglyoxal    O
into    O
the    O
product    O
.    O

In    O
both    O
the    O
hemithioacetal    O
substrate    O
and    O
the    O
(    O
R)-S    O
-    O
lactoylglutathione    O
product    O
,    O
the    O
glutathione    B-Antioxidant114724645
moiety    O
is    O
bonded    O
to    O
the    O
C1    O
carbonyl    O
group    O
.    O

The    O
substrate    O
hemithioacetal    O
is    O
formed    O
when    O
a    O
molecule    O
of    O
glutathione    B-Antioxidant114724645
—    O
probably    O
in    O
its    O
reactive    O
thiolate    O
form    O
—    O
attacks    O
the    O
C1    O
carbonyl    O
of    O
methylglyoxal    O
or    O
a    O
related    O
compound    O
,    O
rendering    O
that    O
carbon    O
tetravalent    O
.    O

Numerous    O
inhibitors    O
have    O
been    O
developed    O
,    O
most    O
of    O
which    O
share    O
the    O
glutathione    B-Antioxidant114724645
moiety    O
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
leukotriene    O
C4    O
,    O
and    O
two    O
products    O
,    O
leukotriene    O
A4    O
and    O
glutathione    B-Antioxidant114724645
.    O

Hence    O
,    O
this    O
enzyme    O
has    O
one    O
substrate    O
,    O
S-(hydroxymethyl)glutathione    O
,    O
and    O
two    O
products    O
,    O
glutathione    B-Antioxidant114724645
and    O
formaldehyde    O
.    O

The    O
NADPH    O
in    O
turn    O
maintains    O
the    O
level    O
of    O
glutathione    B-Antioxidant114724645
in    O
these    O
cells    O
that    O
helps    O
protect    O
the    O
red    O
blood    O
cells    O
against    O
oxidative    O
damage    O
from    O
compounds    O
like    O
hydrogen    O
peroxide    O
.    O

It    O
employs    O
one    O
cofactor    O
,    O
glutathione    B-Antioxidant114724645
.    O

Glutathione    O
S    O
-    O
transferases    O
(    O
GSTs    O
)    O
are    O
a    O
family    O
of    O
enzymes    O
that    O
play    O
an    O
important    O
role    O
in    O
detoxification    O
by    O
catalyzing    O
the    O
conjugation    O
of    O
many    O
hydrophobic    O
and    O
electrophilic    O
compounds    O
with    O
reduced    O
glutathione    B-Antioxidant114724645
.    O

HxA3    O
was    O
converted    O
through    O
a    O
Michael    O
addition    O
catalyzed    O
by    O
glutathione    O
transferase    O
to    O
its    O
glutathione    B-Antioxidant114724645
conjugate    O
,    O
HxA3-C    O
,    O
i.e.    O
,    O
11-glutathionyl    O
-    O
HxA3    O
,    O
in    O
a    O
cell    O
-    O
free    O
system    O
or    O
in    O
homogenates    O
of    O
rat    O
brain    O
hippocampus    O
tissue    O
;    O
HxA3-C    O
proved    O
to    O
be    O
a    O
potent    O
stimulator    O
of    O
membrane    O
hyperpolarization    O
in    O
rat    O
hippocampal    O
CA1    O
neurons    O
.    O

Although    O
inactive    O
at    O
steroid    O
hormone    O
receptors    O
,    O
E2S    O
has    O
been    O
found    O
to    O
act    O
as    O
a    O
potent    O
inhibitor    O
of    O
glutathione    O
S    O
-    O
transferase    O
,    O
an    O
enzyme    O
that    O
contributes    O
to    O
the    O
inactivation    O
of    O
estradiol    O
via    O
conversion    O
of    O
it    O
into    O
an    O
estradiol    O
-    O
glutathione    B-Antioxidant114724645
conjugate    O
.    O

Overexpression    O
of    O
the    O
enzyme    O
which    O
synthesizes    O
glutathione    B-Antioxidant114724645
in    O
long    O
-    O
lived    O
transgenic    O
"    O
Drosophila    O
"    O
(    O
fruit    O
-    O
flies    O
)    O
extended    O
maximum    O
lifespan    O
by    O
nearly    O
50%    O

The    O
amino    O
acids    O
cysteine    O
and    O
methionine    O
are    O
used    O
by    O
the    O
body    O
to    O
make    O
glutathione    B-Antioxidant114724645
.    O

Regarding    O
autism    O
,    O
James    O
'    O
view    O
is    O
that    O
the    O
transsulfuration    O
pathway    O
is    O
disrupted    O
in    O
autistic    O
children    O
,    O
resulting    O
in    O
these    O
children    O
being    O
deficient    O
in    O
glutathione    B-Antioxidant114724645
,    O
as    O
well    O
as    O
vitamins    O
such    O
as    O
vitamin    O
B6    O
and    O
vitamin    O
B12    O
,    O
and    O
that    O
maternal    O
glutathione    O
deficiency    O
may    O
also    O
be    O
a    O
risk    O
factor    O
for    O
autism    O
.    O

As    O
glutathione    B-Antioxidant114724645
depletion    O
has    O
been    O
shown    O
to    O
regulate    O
liver    O
toxification    O
,    O
administration    O
of    O
N    O
-    O
acetylcysteine    O
in    O
similar    O
doses    O
as    O
given    O
for    O
acetaminophen    O
toxicity    O
have    O
been    O
given    O
to    O
patients    O
.    O

This    O
makes    O
ergothioneine    O
much    O
less    O
reactive    O
than    O
thiols    O
such    O
as    O
glutathione    B-Antioxidant114724645
towards    O
alkylating    O
agents    O
like    O
maleimides    O
,    O
and    O
also    O
prevents    O
the    O
compound    O
from    O
oxidizing    O
in    O
air    O
.    O

Glutathione    B-Antioxidant114724645
,    O
important    O
antioxidant    O

This    O
enzyme    O
participates    O
in    O
glutathione    B-Antioxidant114724645
metabolism    I-Antioxidant114724645
.    O

This    O
enzyme    O
participates    O
in    O
glutathione    B-Antioxidant114724645
metabolism    I-Antioxidant114724645
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
glutathione    B-Antioxidant114724645
and    O
[    O
Glu(-Cys)]n    O
-    O
Gly    O
,    O
whereas    O
its    O
two    O
products    O
are    O
Gly    O
and    O
[    O
Glu(-Cys)]n+1-Gly    O
.    O

Some    O
observed    O
effects    O
of    O
exposure    O
to    O
dioxins    O
are    O
altered    O
astroglial    O
intracellular    O
calcium    O
ion    O
(    O
Ca2    O
+    O
)    O
,    O
decreased    O
glutathione    B-Antioxidant114724645
levels    O
,    O
modified    O
neurotransmitter    O
function    O
in    O
the    O
CNS    O
,    O
and    O
loss    O
of    O
pH    O
maintenance    O
.    O

Mercury    O
and    O
lead    O
are    O
particularly    O
neurotoxic    O
for    O
many    O
reasons    O
:    O
they    O
easily    O
cross    O
cell    O
membranes    O
,    O
have    O
oxidative    O
effects    O
on    O
cells    O
,    O
react    O
with    O
sulfur    O
in    O
the    O
body    O
(    O
leading    O
to    O
disturbances    O
in    O
the    O
many    O
functions    O
that    O
rely    O
upon    O
sulfhydryl    O
groups    O
)    O
,    O
and    O
reduce    O
glutathione    B-Antioxidant114724645
levels    O
inside    O
cells    O
.    O

The    O
other    O
route    O
uses    O
glutathione    B-Antioxidant114724645
(    O
GSH    O
)    O
to    O
conjugate    O
with    O
arsenic    O
(    O
III    O
)    O
to    O
form    O
an    O
arsenic    O
(    O
GS    O
)    O
3    O
complex    O
.    O

ArsC    O
is    O
an    O
approximately    O
150-residue    O
arsenate    O
reductase    O
that    O
uses    O
reduced    O
glutathione    B-Antioxidant114724645
(    O
GSH    O
)    O
to    O
convert    O
arsenate    O
to    O
arsenite    O
with    O
a    O
redox    O
active    O
cysteine    O
residue    O
in    O
the    O
active    O
site    O
.    O

Glutathione    B-Antioxidant114724645

EXC4    O
contains    O
glutathione    B-Antioxidant114724645
(    O
i.e.    O
γ-L    O
-    O
glutamyl    O
-    O
L    O
-    O
cysteinylglycine    O
)    O
bound    O
in    O
the    O
"    O
R    O
"    O
configuration    O
to    O
carbon    O
14    O
.    O

,    O
NAD+-dependent    O
15-hydroxyprostaglandin    O
dehydrogenase    O
;    O
15-oxo    O
-    O
ETE    O
,    O
similar    O
to    O
15(S)-HETE    O
,    O
may    O
be    O
acylated    O
into    O
membrane    O
phosphatidylethanolamaine    O
or    O
,    O
similar    O
to    O
15("S")-HpETE    O
,    O
conjugated    O
with    O
glutathione    B-Antioxidant114724645
to    O
form    O
a    O
13-cysteinyl    O
-    O
glycyl    O
-    O
glutamine    O
adduct    O
viz    O
.    O

Dehydroascorbate    O
is    O
reduced    O
to    O
ascorbate    O
by    O
dehydroascorbate    O
reductase    O
at    O
the    O
expense    O
of    O
GSH    B-Antioxidant114724645
,    O
yielding    O
oxidized    O
glutathione    O
(    O
GSSG    O
)    O
.    O

Thus    O
ascorbate    B-Antioxidant114724645
and    O
glutathione    B-Antioxidant114724645
are    O
not    O
consumed    O
;    O
the    O
net    O
electron    O
flow    O
is    O
from    O
NADPH    O
to    O
H2O2    O
.    O

It    O
was    O
found    O
that    O
when    O
chromium    O
(    O
VI    O
)    O
species    O
formed    O
under    O
physiological    O
conditions    O
,    O
they    O
were    O
reduced    O
by    O
vitamin    B-Antioxidant114724645
C    I-Antioxidant114724645
and    O
glutathione    B-Antioxidant114724645
to    O
form    O
reactive    O
intermediate    O
complexes    O
.    O

Cardiac    O
oxidative    O
stress    O
was    O
conferred    O
by    O
accumulation    O
of    O
protein    O
carbonyls    O
,    O
lipid    O
peroxidation    O
and    O
glutathione    B-Antioxidant114724645
production    O
.    O

A    O
significant    O
induction    O
in    O
reactive    O
oxygen    O
species    O
,    O
lipid    O
peroxides    O
,    O
and    O
the    O
ratio    O
of    O
glutathione    O
disulfide    O
/    O
reduced    O
glutathione    B-Antioxidant114724645
was    O
observed    O
in    O
cells    O
exposed    O
to    O
selected    O
doses    O
of    O
monocrotophos    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S    O
-    O
formylglutathione    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
glutathione    B-Antioxidant114724645
and    O
formate    O
.    O

Thus    O
,    O
the    O
two    O
substrates    O
of    O
this    O
enzyme    O
are    O
S    O
-    O
succinylglutathione    O
and    O
H2O    O
,    O
whereas    O
its    O
two    O
products    O
are    O
glutathione    B-Antioxidant114724645
and    O
succinate    O
.    O

Research    O
shows    O
that    O
nitrotyrosine    O
levels    O
can    O
be    O
reduced    O
by    O
N    O
-    O
acetyl    O
cysteine    O
,    O
which    O
is    O
a    O
precursor    O
to    O
glutathione    B-Antioxidant114724645
,    O
one    O
of    O
the    O
body    O
's    O
primary    O
endogenous    O
antioxidants    O
.    O

The    O
particular    O
shade    O
depends    O
upon    O
the    O
amount    O
of    O
fucoxanthin    B-Antioxidant114724645
present    O
in    O
the    O
alga    O
.    O

Their    O
plastids    O
also    O
contain    O
chlorophyll    O
c    O
and    O
carotenoids    O
(    O
the    O
most    O
widespread    O
of    O
those    O
being    O
fucoxanthin    B-Antioxidant114724645
)    O
.    O

The    O
chloroplasts    O
characteristically    O
contain    O
chlorophyll    O
a    O
and    O
chlorophyll    O
c    O
,    O
and    O
usually    O
the    O
accessory    O
pigment    O
fucoxanthin    B-Antioxidant114724645
,    O
giving    O
them    O
a    O
golden    O
-    O
brown    O
or    O
brownish    O
-    O
green    O
color    O
.    O

The    O
brown    O
colour    O
of    O
this    O
seaweed    O
results    O
from    O
the    O
dominance    O
of    O
the    O
xanthophyll    O
fucoxanthin    B-Antioxidant114724645
which    O
masks    O
the    O
other    O
pigments    O
that    O
are    O
present    O
,    O
namely    O
chlorophyll    O
a    O
,    O
chlorophyll    O
c    O
,    O
beta    O
-    O
carotene    O
and    O
other    O
xanthophylls    O
.    O

Xanthophyte    O
chloroplasts    O
contain    O
the    O
photosynthetic    O
pigments    O
chlorophyll    O
"    O
a    O
"    O
,    O
chlorophyll    O
"    O
c    O
"    O
,    O
β-carotene    O
,    O
and    O
the    O
carotenoid    O
diadinoxanthin    B-Antioxidant114724645
.    O

Ozone    O
cracking    O
was    O
once    O
commonly    O
seen    O
in    O
the    O
sidewalls    O
of    O
tires    O
but    O
is    O
now    O
rare    O
owing    O
to    O
the    O
use    O
of    O
antiozonant    B-Antioxidant114724645
.    O

PPD    O
is    O
easily    O
oxidized    O
,    O
and    O
for    O
this    O
reason    O
derivatives    O
of    O
PPD    O
are    O
used    O
as    O
antiozonant    B-Antioxidant114724645
in    O
production    O
of    O
rubber    O
products    O
.    O

Retinoid    B-Antioxidant114724645
(    O
e.g.    O
,    O
isotretinoin    O
)    O

Additional    O
treatments    O
include    O
retinoid    B-Antioxidant114724645
,    O
such    O
as    O
acitretin    O
,    O
or    O
sulfasalazine    O
.    O

Common    O
treatments    O
include    O
simple    O
sunlight    O
,    O
ultraviolet    O
light    O
(    O
mainly    O
NB    O
-    O
UVB    O
312    O
nm    O
)    O
,    O
topical    O
steroids    O
,    O
topical    O
and    O
systemic    O
chemotherapies    O
,    O
local    O
superficial    O
radiotherapy    O
,    O
the    O
histone    O
deacetylase    O
inhibitor    O
vorinostat    O
,    O
total    O
skin    O
electron    O
beam    O
radiation    O
,    O
photopheresis    O
and    O
systemic    O
therapies    O
(    O
e.g.    O
interferons    O
,    O
retinoid    B-Antioxidant114724645
,    O
rexinoids    O
)    O
or    O
biological    O
therapies    O
.    O

Adarotene    O
is    O
a    O
bioactive    O
retinoid    B-Antioxidant114724645
.    O

Retinoic    O
acid    O
is    O
a    O
retinoid    B-Antioxidant114724645
.    O

UV    O
irradiation    O
can    O
be    O
utilized    O
after    O
curetting    O
the    O
hyperkeratosis    O
with    O
a    O
combination    O
medication    O
treatment    O
of    O
oral    O
retinoid    B-Antioxidant114724645
,    O
psoralen    O
and    O
Ultraviolet    O
A    O
radiation    O
.    O

Topical    O
corticosteroid    O
preparations    O
are    O
the    O
most    O
effective    O
agents    O
when    O
used    O
continuously    O
for    O
8    O
weeks    O
;    O
retinoid    B-Antioxidant114724645
and    O
coal    O
tar    O
were    O
found    O
to    O
be    O
of    O
limited    O
benefit    O
and    O
may    O
be    O
no    O
better    O
than    O
placebo    O
.    O

Ointment    O
and    O
creams    O
containing    O
coal    O
tar    O
,    O
dithranol    O
,    O
corticosteroids    O
(    O
i.e.    O
desoximetasone    O
)    O
,    O
fluocinonide    O
,    O
vitamin    O
D3    O
analogs    O
(    O
for    O
example    O
,    O
calcipotriol    O
)    O
,    O
and    O
retinoid    B-Antioxidant114724645
are    O
routinely    O
used    O
.    O

Non    O
-    O
biologic    O
systemic    O
treatments    O
frequently    O
used    O
for    O
psoriasis    O
include    O
methotrexate    O
,    O
ciclosporin    O
,    O
hydroxycarbamide    O
,    O
fumarates    O
such    O
as    O
dimethyl    O
fumarate    O
,    O
and    O
retinoids    B-Antioxidant114724645
.    O

Topical    O
creams    O
and    O
lotions    O
are    O
currently    O
the    O
most    O
commonly    O
used    O
treatment    O
for    O
keratosis    O
pilaris    O
,    O
specifically    O
those    O
consisting    O
of    O
moisturizing    O
or    O
keratolytic    O
treatments    O
,    O
including    O
urea    O
,    O
lactic    O
acid    O
,    O
glycolic    O
acid    O
,    O
salicylic    O
acid    O
,    O
vitamin    O
D    O
,    O
or    O
topical    O
retinoids    B-Antioxidant114724645
such    O
as    O
tretinoin    O
.    O

Involved    O
in    O
retinoid    B-Antioxidant114724645
metabolism    O
.    O

Zeaxanthin    O
is    O
epoxidized    O
to    O
form    O
violaxanthin    B-Antioxidant114724645
or    O
neoxanthin    O
.    O

Eustigmatophytes    O
contain    O
one    O
or    O
more    O
yellow    O
-    O
green    O
chloroplasts    O
,    O
which    O
contain    O
chlorophyll    O
a    O
and    O
the    O
accessory    O
pigments    O
violaxanthin    B-Antioxidant114724645
and    O
β-carotene    O
.    O

More    O
recently    O
,    O
he    O
participated    O
in    O
a    O
research    O
team    O
who    O
studied    O
how    O
garlic    O
works    O
at    O
the    O
molecular    O
level    O
,    O
thanks    O
to    O
a    O
unique    O
biotechnological    O
procedure    O
for    O
producing    O
large    O
quantities    O
of    O
pure    O
allicin    B-Antioxidant114724645
,    O
garlic    O
's    O
main    O
biologically    O
active    O
component    O
.    O

Beginning    O
in    O
1944    O
,    O
with    O
his    O
colleagues    O
,    O
he    O
reported    O
on    O
the    O
isolation    O
from    O
crushed    O
garlic    O
,    O
synthesis    O
(    O
from    O
diallyl    O
disulfide    O
)    O
and    O
antibiotic    O
activity    O
of    O
a    O
compound    O
he    O
named    O
allicin    B-Antioxidant114724645
.    O

Ajoene    O
is    O
formed    O
from    O
a    O
chemical    O
reaction    O
involving    O
two    O
allicin    B-Antioxidant114724645
molecules    O
.    O

Allicin    B-Antioxidant114724645
,    O
the    O
biosynthetic    O
precursor    O
to    O
ajoene    O
.    O

Allicin    B-Antioxidant114724645
,    O
the    O
active    O
piquant    O
flavor    O
chemical    O
in    O
uncooked    O
garlic    O
,    O
and    O
to    O
a    O
lesser    O
extent    O
onions    O
(    O
see    O
those    O
articles    O
for    O
discussion    O
of    O
other    O
chemicals    O
in    O
them    O
relating    O
to    O
pungency    O
,    O
and    O
eye    O
irritation    O
)    O

Allicin    B-Antioxidant114724645

Easy    O
Cheese    O
contains    O
milk    O
,    O
water    O
,    O
whey    O
protein    O
concentrate    O
,    O
canola    O
oil    O
,    O
milk    O
protein    O
concentrate    O
,    O
sodium    O
citrate    O
,    O
sodium    O
phosphate    O
,    O
calcium    O
phosphate    O
,    O
lactic    O
acid    O
,    O
sorbic    O
acid    O
,    O
sodium    O
alginate    O
,    O
apocarotenal    B-Antioxidant114724645
,    O
annatto    B-Antioxidant114724645
,    O
cheese    O
culture    O
,    O
and    O
enzymes    O
.    O

The    O
condensation    O
of    O
salicylaldehyde    O
and    O
ethylenediamine    B-Antioxidant114724645
give    O
families    O
of    O
imine    O
-    O
containing    O
chelating    O
agents    O
such    O
as    O
salen    O
.    O

This    O
is    O
accomplished    O
by    O
dynamic    O
covalent    O
chemistry    O
in    O
a    O
one    O
-    O
pot    O
condensation    O
of    O
6    O
equivalents    O
of    O
a    O
tetraformyl    O
calixarene    O
and    O
12    O
equivalents    O
of    O
ethylene    B-Antioxidant114724645
diamine    I-Antioxidant114724645
with    O
trifluoroacetic    O
acid    O
catalyst    O
in    O
chloroform    O
at    O
room    O
temperature    O
followed    O
by    O
reduction    O
of    O
the    O
imine    O
bonds    O
with    O
sodium    O
borohydride    O
.    O

Ethylenediamine    B-Antioxidant114724645
,    O
C2H8N2    O
,    O
an    O
organic    O
compound    O

Polydentate    O
ligands    O
can    O
also    O
be    O
used    O
in    O
the    O
analogy    O
,    O
such    O
as    O
ethylenediamine    B-Antioxidant114724645
,    O
a    O
bidentate    O
ligand    O
,    O
or    O
triethylenetetramine    O
,    O
a    O
tetradentate    O
ligand    O
.    O

The    O
compound    O
is    O
derived    O
from    O
the    O
reaction    O
of    O
ethylenediamine    B-Antioxidant114724645
and    O
stearic    O
acid    O
.    O

One    O
salt    O
that    O
can    O
be    O
formed    O
this    O
way    O
is    O
when    O
cryptand    O
reacts    O
with    O
sodium    O
and    O
lead    O
in    O
ethylenediamine    B-Antioxidant114724645
to    O
produce    O
[    O
Na(crypt)]2+[Pb5]2−    O
,    O
which    O
is    O
red    O
in    O
solution    O
.    O

This    O
is    O
not    O
a    O
simple    O
Zintl    O
compound    O
,    O
but    O
rather    O
contains    O
the    O
organic    O
molecules    O
18-crown-6    O
and    O
ethylenediamine    B-Antioxidant114724645
(    O
en    O
)    O
in    O
order    O
to    O
stabilize    O
the    O
crystal    O
structure    O
.    O

For    O
example    O
,    O
copper(II    O
)    O
hydroxide    O
catalyzes    O
the    O
reaction    O
of    O
ethylenediamine    B-Antioxidant114724645
with    O
1-bromoanthraquinone    O
or    O
1-amino-4-bromoanthraquinone    O
to    O
form    O
1-((2-aminoethyl)amino)anthraquinone    O
or    O
1-amino-4-((2-aminoethyl)amino)anthraquinone    O
,    O
respectively    O
:    O

For    O
example    O
,    O
reacting    O
ethanolamine    O
with    O
ammonia    O
gives    O
ethylenediamine    B-Antioxidant114724645
,    O
a    O
precursor    O
of    O
the    O
commonly    O
used    O
chelating    O
agent    O
,    O
EDTA    O
:    O

The    O
reaction    O
of    O
Ge    O
,    O
Sn    O
or    O
Pb    O
and    O
Na    O
in    O
liquid    O
NH3    O
in    O
the    O
presence    O
of    O
ethylene    B-Antioxidant114724645
diamine    I-Antioxidant114724645
(    O
en    O
)    O
gives    O
the    O
Zintl    O
cluster    O
Na4en7Sn9    O
.    O

Ethylene    B-Antioxidant114724645
diamine    I-Antioxidant114724645
,    O
an    O
organic    O
compound    O

Tris(ethylenediamine)cobalt(III    O
)    O
chloride    O
is    O
a    O
coordination    O
complex    O
with    O
the    O
formula    O
[    O
Co(en)3]Cl3    O
(    O
where    O
"    O
en    O
"    O
is    O
the    O
abbreviation    O
for    O
ethylenediamine    B-Antioxidant114724645
)    O
.    O

Polyphenols    O
in    O
tea    O
include    O
catechins    B-Antioxidant114724645
,    O
theaflavin    B-Antioxidant114724645
,    O
tannins    O
,    O
and    O
flavonoids    O
.    O

Polyphenols    O
found    O
in    O
green    O
tea    O
include    O
but    O
are    O
not    O
limited    O
to    O
epigallocatechin    B-Antioxidant114724645
gallate    I-Antioxidant114724645
(EGCG)    I-Antioxidant114724645
,    O
epigallocatechin    O
,    O
epicatechin    O
gallate    O
,    O
and    O
epicatechin    B-Antioxidant114724645
;    O
flavanol    B-Antioxidant114724645
such    O
as    O
kaempferol    O
,    O
quercetin    O
,    O
and    O
myricitin    O
are    O
also    O
found    O
in    O
green    O
tea    O
.    O

Catechins    B-Antioxidant114724645
are    O
the    O
largest    O
type    O
of    O
flavonoids    O
in    O
growing    O
tea    O
leaves    O
.    O

Most    O
of    O
the    O
polyphenols    O
in    O
green    O
tea    O
are    O
flavan-3-ol    B-Antioxidant114724645
(    O
"    O
catechins    O
"    O
)    O
.    O

Apple    O
juice    O
has    O
a    O
significant    O
concentration    O
of    O
natural    O
phenols    O
of    O
low    O
molecular    O
weight    O
(    O
including    O
chlorogenic    O
acid    O
,    O
flavan-3-ol    B-Antioxidant114724645
,    O
and    O
flavonol    B-Antioxidant114724645
)    O
and    O
procyanidin    B-Antioxidant114724645
.    O

They    O
are    O
oligomers    O
of    O
flavan-3-ol    B-Antioxidant114724645
.    O

Flavonol    B-Antioxidant114724645
were    O
found    O
to    O
be    O
the    O
predominating    O
class    O
of    O
phenolic    O
compounds    O
while    O
phenolic    O
acids    O
and    O
flavan-3-ol    B-Antioxidant114724645
(    O
"    O
catechins    O
"    O
)    O
represent    O
minor    O
components    O
.    O

CocoaVia    O
featured    O
a    O
line    O
of    O
dark    O
chocolate    O
bars    O
and    O
chews    O
that    O
contained    O
cocoa    O
flavanols    B-Antioxidant114724645
and    O
plant    O
sterols    O
.    O

Through    O
derivatives    O
of    O
the    O
flavanol    B-Antioxidant114724645
in    O
its    O
extracts    O
,    O
the    O
species    O
has    O
lent    O
its    O
name    O
to    O
the    O
important    O
catechin    B-Antioxidant114724645
,    O
catechols    O
and    O
catecholamines    O
of    O
chemistry    O
and    O
biology    O
.    O

Gamma-    B-Antioxidant114724645
,    O
delta-    B-Antioxidant114724645
,    O
epsilon-    B-Antioxidant114724645
,    O
and    O
zeta-carotene    B-Antioxidant114724645
(    O
γ    O
,    O
δ    O
,    O
ε    O
,    O
and    O
ζ-carotene    O
)    O
also    O
exist    O
.    O

Phytoene    O
then    O
goes    O
through    O
a    O
series    O
of    O
desaturation    O
reactions    O
using    O
the    O
enzyme    O
phytoene    O
desaturase    O
(    O
PDS    O
)    O
to    O
produce    O
phytofluene    B-Antioxidant114724645
then    O
ζ-carotene    B-Antioxidant114724645
.    O

Ammonium    B-Antioxidant114724645
fumarate    I-Antioxidant114724645
is    O
a    O
compound    O
with    O
formula    O
(    O
NH4)2(C2H2(COO)2    O
)    O
.    O

It    O
is    O
a    O
synergistic    O
antioxidant    O
with    O
butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
(    O
BHT    O
)    O
and    O
butylated    B-Antioxidant114724645
hydroxyanisole    I-Antioxidant114724645
(    O
BHA    O
)    O
.    O

Since    O
the    O
1970s    O
,    O
BHT    O
has    O
been    O
steadily    O
replaced    O
with    O
butylated    B-Antioxidant114724645
hydroxyanisole    I-Antioxidant114724645
(    O
BHA    O
)    O
.    O

Butylated    B-Antioxidant114724645
hydroxyanisole    I-Antioxidant114724645
(    O
BHA    B-Antioxidant114724645
)    O
is    O
an    O
antioxidant    O
consisting    O
of    O
a    O
mixture    O
of    O
two    O
isomeric    O
organic    O
compounds    O
,    O
2-"tert    O
"-    O
butyl-4-hydroxyanisole    O
and    O
3-"tert    O
"-    O
butyl-4-hydroxyanisole    O
.    O

Butylated    B-Antioxidant114724645
hydroxyanisole    I-Antioxidant114724645
,    O
a    O
food    O
additive    O

Glutathione    O
peroxidases    O
:    O
GPX1    O
,    O
GPX2    O
,    O
GPX3    B-Antioxidant114724645
,    O
GPX4    O
,    O
GPX6    B-Antioxidant114724645

Ionone    B-Antioxidant114724645

Certain    O
materials    O
are    O
ubiquitous    O
in    O
Guerlain    O
’s    O
work    O
:    O
high    O
quality    O
citruses    O
(    O
bergamot    O
,    O
citron    O
,    O
mandarin    O
,    O
sweet    O
and    O
bitter    O
orange    O
)    O
,    O
coumarin    O
,    O
floral    O
absolutes    O
(    O
cassie    O
,    O
jasmine    O
,    O
rose    O
,    O
orange    O
blossom    O
)    O
,    O
green    O
notes    O
(    O
galbanum    O
)    O
,    O
violet    O
-    O
smelling    O
ionones    B-Antioxidant114724645
and    O
fine    O
qualities    O
of    O
orris    O
,    O
vanilla    O
and    O
ylang    O
-    O
ylang    O
.    O

Ionone    B-Antioxidant114724645

Carotenes    O
and    O
carotenoids    O
,    O
such    O
as    O
the    O
acyclic    O
lycopene    O
,    O
the    O
monocyclic    O
γ-carotene    B-Antioxidant114724645
,    O
and    O
the    O
bicyclic    O
α-    O
and    O
β-carotenes    O

Biologically    O
important    O
tetraterpenoids    O
include    O
the    O
acyclic    O
lycopene    O
,    O
the    O
monocyclic    O
gamma-carotene    B-Antioxidant114724645
,    O
and    O
the    O
bicyclic    O
alpha-    O
and    O
beta    O
-    O
carotenes    O
.    O

A    O
form    O
of    O
nordihydroguaiaretic    B-Antioxidant114724645
acid    I-Antioxidant114724645
that    O
is    O
taken    O
by    O
mouth    O
is    O
being    O
studied    O
in    O
the    O
treatment    O
of    O
prostate    O
cancer    O
.    O

:    O
(    O
1a    O
)    O
2    O
geranylgeranyl    O
diphosphate    O
diphosphate    O
+    O
prephytoene    B-Antioxidant114724645
diphosphate    I-Antioxidant114724645

In    O
diatoms    O
and    O
dinoflagellates    O
,    O
the    O
xanthophyll    O
cycle    O
consists    O
of    O
the    O
pigment    O
diadinoxanthin    B-Antioxidant114724645
,    O
which    O
is    O
transformed    O
into    O
diatoxanthin    B-Antioxidant114724645
(    O
diatoms    O
)    O
or    O
dinoxanthin    B-Antioxidant114724645
(    O
dinoflagellates    O
)    O
under    O
high    O
-    O
light    O
conditions    O
.    O

It    O
is    O
seasoned    O
with    O
liquid    O
from    O
the    O
meat    O
mixture    O
,    O
milk    O
,    O
and    O
annatto    B-Antioxidant114724645
oil    I-Antioxidant114724645
.    O

It    O
is    O
also    O
used    O
to    O
repel    O
mosquitoes    O
by    O
forming    O
an    O
oilseed    O
cake    O
into    O
balls    O
and    O
burned    O
,    O
or    O
mixed    O
with    O
annatto    B-Antioxidant114724645
(    O
"    O
Bixa    O
orellana    O
"    O
)    O
and    O
formed    O
into    O
a    O
paste    O
applied    O
topically    O
to    O
protect    O
the    O
body    O
from    O
mosquito    O
bites    O
.    O

For    O
the    O
preparation    O
of    O
Herbal    O
Gulal    O
,    O
lots    O
of    O
safe    O
dyes    O
can    O
be    O
used    O
,    O
such    O
as    O
Turmeric    O
(    O
Curcuma    O
Longa    O
)    O
,    O
Indigo    O
(    O
Indigofera    O
)    O
or    O
Annatto    B-Antioxidant114724645
(    O
Bixa    O
Orellana    O
)    O
,    O
which    O
are    O
all    O
ingredients    O
easily    O
available    O
on    O
the    O
market    O
at    O
moderate    O
prices    O
.    O

Agricultural    O
products    O
include    O
coffee    O
,    O
sugar    O
cane    O
,    O
tobacco    O
,    O
maize    O
,    O
beans    O
,    O
cacao    O
,    O
annatto    B-Antioxidant114724645
,    O
tomatoes    O
,    O
vanilla    O
,    O
cotton    O
,    O
and    O
a    O
variety    O
of    O
other    O
fruits    O
.    O

Farmers    O
in    O
the    O
area    O
near    O
Leiden    O
added    O
cumin    O
seeds    O
and    O
used    O
to    O
colour    O
their    O
cheeses    O
using    O
anatto    B-Antioxidant114724645
,    O
which    O
gives    O
the    O
cheese    O
its    O
red    O
color    O
.    O

Since    O
the    O
18th    O
century    O
it    O
has    O
been    O
coloured    O
orange    O
by    O
adding    O
annatto    B-Antioxidant114724645
extract    O
during    O
manufacture    O
.    O

She    O
was    O
carrying    O
a    O
cargo    O
of    O
drugs    O
,    O
annatto    B-Antioxidant114724645
,    O
cochineal    O
,    O
indigo    O
and    O
sugar    O
,    O
and    O
some    O
1,500,000    O
dollars    O
.    O

Anise    O
wine    O
,    O
annatto    B-Antioxidant114724645
,    O
water    O
,    O
sugar    O
,    O
and    O
salt    O
are    O
then    O
combined    O
in    O
a    O
container    O
to    O
make    O
a    O
mixture    O
.    O

The    O
red    O
orange    O
color    O
is    O
from    O
the    O
addition    O
of    O
annatto    B-Antioxidant114724645
seeds    O
.    O

"    O
Longganisa    O
"    O
is    O
a    O
sweet    O
or    O
spicy    O
sausage    O
,    O
typically    O
made    O
from    O
pork    O
though    O
other    O
meats    O
can    O
also    O
be    O
used    O
,    O
and    O
are    O
often    O
colored    O
red    O
traditionally    O
through    O
the    O
use    O
of    O
the    O
anatto    B-Antioxidant114724645
seed    O
but    O
also    O
artificial    O
food    O
coloring    O
.    O

Red    O
rice    O
made    O
with    O
achoti    B-Antioxidant114724645
is    O
a    O
distinct    O
staple    O
food    O
that    O
strongly    O
identifies    O
Chamoru    O
cuisine    O
among    O
the    O
many    O
dishes    O
of    O
fellow    O
Pacific    O
island    O
cultures    O
.    O

The    O
Yanesha    O
'    O
people    O
once    O
lived    O
through    O
hunting    O
,    O
fishing    O
,    O
and    O
subsistence    O
agriculture    O
;    O
in    O
modern    O
times    O
,    O
the    O
emphasis    O
is    O
on    O
agricultural    O
diversification    O
and    O
cultivation    O
of    O
cash    O
crops    O
like    O
coffee    O
and    O
annatto    B-Antioxidant114724645
.    O

Easy    O
Cheese    O
contains    O
milk    O
,    O
water    O
,    O
whey    O
protein    O
concentrate    O
,    O
canola    O
oil    O
,    O
milk    O
protein    O
concentrate    O
,    O
sodium    O
citrate    O
,    O
sodium    O
phosphate    O
,    O
calcium    O
phosphate    O
,    O
lactic    O
acid    O
,    O
sorbic    O
acid    O
,    O
sodium    O
alginate    O
,    O
apocarotenal    B-Antioxidant114724645
,    O
annatto    B-Antioxidant114724645
,    O
cheese    O
culture    O
,    O
and    O
enzymes    O
.    O

PeroxiRedoxin    B-Antioxidant114724645
classification    I-Antioxidant114724645
indEX    I-Antioxidant114724645
(    O
PREX    B-Antioxidant114724645
)    O
is    O
a    O
database    O
of    O
peroxiredoxins    O
(    O
Prxs    O
)    O
classified    O
into    O
one    O
of    O
six    O
distinct    O
subfamilies    O
.    O

In    O
diatoms    O
and    O
dinoflagellates    O
,    O
the    O
xanthophyll    O
cycle    O
consists    O
of    O
the    O
pigment    O
diadinoxanthin    B-Antioxidant114724645
,    O
which    O
is    O
transformed    O
into    O
diatoxanthin    B-Antioxidant114724645
(    O
diatoms    O
)    O
or    O
dinoxanthin    B-Antioxidant114724645
(    O
dinoflagellates    O
)    O
under    O
high    O
-    O
light    O
conditions    O
.    O

δ-Carotene    B-Antioxidant114724645

For    O
example    O
,    O
the    O
of    O
2,6-di-tert-butylphenol    B-Antioxidant114724645
is    O
greater    O
than    O
9    O
g    O
/    O
kg    O
.    O

They    O
additionally    O
contain    O
water    O
-    O
soluble    O
protein    O
-    O
pigment    O
complexes    O
that    O
exploit    O
carotenoids    O
such    O
as    O
peridinin    B-Antioxidant114724645
to    O
extend    O
their    O
photosynthetic    O
capacity    O
.    O

SureLight    O
Dyes    O
(    O
APC    O
,    O
PerCP    B-Antioxidant114724645
,    O
Phycobilisomes)(Columbia    O
Biosciences    O
)    O

Butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
(    O
BHT    B-Antioxidant114724645
)    O
,    O
also    O
known    O
as    O
dibutylhydroxytoluene    B-Antioxidant114724645
,    O
is    O
a    O
lipophilic    O
organic    O
compound    O
,    O
chemically    O
a    O
derivative    O
of    O
phenol    O
,    O
that    O
is    O
useful    O
for    O
its    O
antioxidant    O
properties    O
.    O

Like    O
butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
(    O
BHT    O
)    O
,    O
the    O
conjugated    O
aromatic    O
ring    O
of    O
BHA    O
is    O
able    O
to    O
stabilize    O
free    O
radicals    O
,    O
sequestering    O
them    O
.    O

The    O
dinners    O
are    O
almost    O
always    O
significantly    O
less    O
nutritious    O
than    O
fresh    O
food    O
and    O
are    O
formulated    O
to    O
remain    O
edible    O
after    O
long    O
periods    O
of    O
storage    O
,    O
thus    O
often    O
requiring    O
preservatives    O
such    O
as    O
butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
.    O

The    O
main    O
ingredients    O
in    O
Dubble    O
Bubble    O
gum    O
are    O
Sugar    O
,    O
Dextrose    O
,    O
Corn    O
Syrup    O
,    O
Gum    O
Base    O
,    O
Tapioca    O
Dextrin    O
,    O
Titanium    O
Dioxide    O
,    O
Confectioner    O
's    O
Glaze    O
,    O
Carnauba    O
Wax    O
,    O
Corn    O
Starch    O
,    O
Artificial    O
Flavors    O
,    O
Artificial    O
Colors    O
,    O
(    O
FD&C    O
Red    O
40    O
,    O
Blue    O
1    O
,    O
Yellow    O
5    O
,    O
Yellow    O
6    O
,    O
Red    O
3    O
)    O
,    O
and    O
BHT    B-Antioxidant114724645
(    O
to    O
maintain    O
freshness    O
)    O
.    O

The    O
ingredients    O
of    O
"    O
1928    O
Original    O
"    O
Dubble    O
Bubble    O
gum    O
are    O
Sugar    O
,    O
Dextrose    O
,    O
Corn    O
Syrup    O
,    O
Gum    O
Base    O
,    O
High    O
Fructose    O
Corn    O
Syrup    O
,    O
Artificial    O
Flavor    O
,    O
Colour    O
,    O
Corn    O
Starch    O
and    O
BHT    B-Antioxidant114724645
.    O

In    O
1968    O
Harman    O
published    O
a    O
dietary    O
antioxidant    O
study    O
showing    O
that    O
the    O
food    O
preservative    O
BHT    B-Antioxidant114724645
fed    O
over    O
a    O
lifetime    O
to    O
mice    O
produced    O
a    O
45%    O
increase    O
in    O
life    O
span    O
.    O

"    O
p    O
"-    O
Cresol    O
is    O
mainly    O
consumed    O
in    O
the    O
production    O
of    O
antioxidants    O
,    O
e.g.    O
,    O
butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
(    O
BHT    O
)    O
.    O

B.    O
braunii    O
"    O
is    O
also    O
the    O
subject    O
of    O
research    O
into    O
the    O
natural    O
production    O
of    O
butylated    B-Antioxidant114724645
hydroxytoluene    I-Antioxidant114724645
(    O
BHT    O
)    O
,    O
an    O
antioxidant    O
,    O
food    O
additive    O
,    O
and    O
industrial    O
chemical    O
.    O

Erdosteine    O
300    O
mg    O
twice    O
daily    O
reduced    O
cough    O
(    O
both    O
frequency    O
and    O
severity    O
)    O
and    O
sputum    O
viscosity    O
more    O
quickly    O
and    O
more    O
effectively    O
than    O
placebo    O
and    O
reduced    O
the    O
adhesivity    O
of    O
sputum    O
more    O
effectively    O
than    O
bromhexine    B-Antioxidant114724645
30    O
mg    O
twice    O
daily    O
.    O

Citranaxanthin    B-Antioxidant114724645
is    O
a    O
carotenoid    O
pigment    O
used    O
as    O
a    O
food    O
additive    O
under    O
the    O
E    O
number    O
E161i    O
as    O
a    O
food    O
coloring    O
.    O

The    O
upper    O
part    O
of    O
the    O
cap    O
,    O
which    O
contains    O
3.1    O
micrograms    O
of    O
carotenoid    O
per    O
gram    O
(    O
µg    O
/    O
g    O
)    O
fresh    O
weight    O
,    O
has    O
predominantly    O
mutatochrome    B-Antioxidant114724645
(    O
47%    O
of    O
total    O
carotenoids    O
)    O
,    O
4-keto-α-carotene    O
(    O
40.2%    O
)    O
,    O
and    O
δ-carotene    B-Antioxidant114724645
(    O
6.4%    O
)    O
.    O

1,2-Diaminopropane    B-Antioxidant114724645
(    O
1,2-propanediamine    B-Antioxidant114724645
)    O
is    O
organic    O
compound    O
with    O
the    O
formula    O
CH3CH(NH2)CH2NH2    O
.    O


